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Movement disorders are a subset of neurological conditions that are responsible 
for a significant decline in the health of the world’s population, having multiple negative 
impacts on the lives of patients, their families, societies and countries’ economy. 
Parkinson’s disease (PD), the most common of all movement disorders, remains 
idiopathic (of unknown cause), is incurable, and without any confirmed pathological 
marker that can be extracted from living patients. As a degenerative condition, early and 
accurate diagnosis is critical for effective disease management in order to preserve a good 
quality of life.  It also requires an in-depth understanding of clinical symptoms to 
differentiate the disease from other movement disorders. Unfortunately, clinical diagnosis 
of PD and other movement disorders is subject to the subjective interpretation of 
clinicians, resulting in a high rate of misdiagnosis of up to 25%. However, computerised 
methods can support clinical diagnosis through objective assessment. The major focus of 
this study is to investigate the use of machine learning approaches, specifically 
evolutionary algorithms, to diagnose, differentiate and characterise different movement 
disorders, namely PD, Huntington disease (HD) and Essential Tremor (ET). In the first 
study, movement features of three standard motor tasks from Unified Parkinson’s Disease 
Rating Scale (UPDRS), finger tapping, hand opening-closing and hand pronation-
supination, were used to evolve the high-performance classifiers. The results obtained for 
these conditions are encouraging, showing differences between the groups of healthy 
controls, PD, HD and ET patients. Findings on the most discriminating features of the 
best classifiers provide insight into different characteristics of the neurological disorders 
under consideration. The same algorithm has also been applied in the second study on 
Dystonia patients. A differential classification between Organic Dystonia and Functional 
Dystonia patients is less convincing, but positive enough to recommend future studies.
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Introduction 
This chapter provides an overview of the thesis, motivations for the work, the hypothesis 
and the contributions made. 
1.1 Overview 
Human body movement is a result of a complex system comprising our brain, spinal cord, 
nerves and muscles. When a human has a desire or need to move, a specific part of the 
brain sends signals through the spinal cord and nerves to the muscles. Muscles that are 
attached to the bones of the skeletal system along with other moving parts such as skin 
and soft tissues are responsible for human movement. If there are problems in the part of 
the brain responsible for sending the signals or failure of the signals to reach the muscles 
as intended, movement disorders can occur. The term ‘movement disorder’ was coined 
in late 1960’s and since then has become a distinct domain. Movement disorders are a 
sub-set of neurological conditions which in turn are the biggest cause of loss of healthy 
life in the world’s population. Examples of common and well-known movement disorders 
are Parkinson’s disease, dystonia, essential tremor and a range of diseases known 
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collectively as atypical parkinsonism. Some of these diseases worsen over time and, 
hence, are known as neurodegenerative disorders. Some are hereditary, such as 
Huntington’s disease and Wilson’s disease. Movement disorders symptoms vary from the 
slowing of movements, spontaneous muscle contractions, to repetitive and involuntary 
movements such as grimacing or eye blinking. They also come with non-motor symptoms 
such as depression, dementia, sleep disorders and pain. 
Being able to move our body normally is a most important part of every-day 
living. Inability to do so has many implications for quality of life and the care required. 
Movement disorders cause multiple impacts to a patient, family, society and the country’s 
economy. One of the important efforts to reduce this impact is an early and accurate 
diagnosis. Unfortunately, clinical diagnosis of movement disorders is subject to the 
interpretation of clinicians, causing a high rate of misdiagnosis. Computerised methods 
can support clinical diagnosis through objective assessment. However, many of the 
computerised methods can be expensive, need experts to operate or are too specific to a 
certain type of disorder. Therefore, this research proposes a computerised method that 
can be used on a range of movement disorders at relatively low cost, that is reliable in a 
conventional clinical setting and provides an objective assessment to support a clinical 
diagnosis. This method manipulates real-time kinematic data of movement disorders from 
patients performing basic motor tasks, acquired using electromagnetic tracking sensors to 
build classifiers employing Evolutionary Algorithms (EAs). EAs are a type of a machine 
learning method that is inspired by natural evolution. The classifiers evolved have been 
trained to identify a specific movement disorder with the added benefit of characterising 
the features of the disorder. Movement disorders of interest in this research are 
Parkinson’s disease (PD), essential tremor (ET), Huntington’s disease (HD), dystonia and 
functional (psychogenic) dystonia. 
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1.2 Motivation 
Movement disorders are a category of neurological disorders. Neurological disorders, 
also known as central nervous disorders, are conditions caused by an abnormality in the 
human central nervous system. The symptoms vary according to which part of the brain 
is affected. In Europe, neurological disorders are classed as the highest contributor to 
global burden of disease (GBD) that assesses mortality and disability (World Health 
Organization, 2006). In the latest analysis of 2015, the worldwide GBD study found that 
neurological disorders as a group is the largest cause of loss of healthy life and second 
only as causes of global death (Naghavi et al., 2015). 
With the exception of Alzheimer’s disease, movement disorders such as Parkinson’s 
disease, essential tremor, restless legs syndrome and dystonia, are the most common 
neurological conditions (Wenning et al., 2000). In 2005, over one million people in 
Europe were diagnosed with Parkinson’s disease, with around 127000 of them living in 
the United Kingdom. It has been projected that the number will double by 2030 (Dorsey 
et al., 2007). Approximately 2.2% of the US population have essential tremor, some 6.38 
to 7.63 million people (Louis & Ottman, 2014). These disorders afflicted not only the 
patients; they pose a challenge to families, caregivers, communities, the health care 
system and the economy. 
 
Cost 
The economic cost of movement disorders is high, consisting of public health delivery 
activities that include formal health care, personal medical attention, home care and self- 
care, health promotion and disease prevention (World Health Organization, 2006). It was 
estimated in 2011 European countries spent 13.9 billion euros on public health deliveries 
for Parkinson’s disease alone. While in the United States, the national economic burden 
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of PD exceeds $14.4 billion in 2010 (EPDA, 2012; Kowal et al., 2013). Apart from direct 
costs, there are indirect costs that result from job loss, change in worker productivity, 
reduced earning ability and missed work days caused by the disease. In fact, indirect cost 
became the bigger part of the economic burden especially in advance stages of the disease 
(Keränen et al., 2003). The high cost of economic burden is linked to not only to the 
financial burden but also to the quality of life of patients and their families (Dowding et 
al., 2006). 
 
Quality of life (QOL) 
The symptoms of movement disorders are many-fold. A few examples are slow decreased 
movement, spontaneous muscle contractions, repetitive and involuntary movements such 
as grimacing or eye blinking and involuntary rhythmic shaking of parts of the body. Apart 
from motor symptoms, there are also non-motor components, such as olfactory 
dysfunction (disturbances of smell and taste), depression, dementia, sleep disorders, 
bowel and bladder problems, fatigue, apathy (lack of emotion, passion, interest or 
motivation) and pain. Although these abnormalities and disturbances in movement have 
a major impact on health, they are rarely a direct cause of death. Instead, the conditions 
result in disabilities that affect the patient’s functioning and quality of life. The symptoms 
cause a decrease in quality of living (QOL) in many ways including loss of independence, 
negative impact on relationships and work, and difficulties in performing day-to-day 
activities (Dowding et al., 2006; Soh et al., 2013; World Health Organization, 2006). The 
disorders affect QOL not only of the patients, but the caregivers as well (Carter et al., 
2008; Martínez-Martín et al., 2005, 2007). The degrading quality of life of patients and 
caregivers is especially true for neurodegenerative disorders such as PD and HD where 
the burden increases as the disease progresses. In addition, recent research also indicates 
that the most common movement disorder, essential tremor, might also worsen over time 
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(Louis et al., 2016). In order to reduce the burden caused by movement disorders, well- 
planned, efficient disease management programs are critical. However, the first step of 
such program, must be an accurate diagnosis. 
1.3 Clinical diagnosis of movement disorders 
One of the critical parts of the management of a disease is the diagnosis. Diagnostic tests 
are imperative to provide information about the patient’s condition, to influence the health 
care provider’s plan for managing the patient and to understand disease mechanism and 
its history through research. However, for most movement disorders, diagnosis proves to 
be difficult and requires experts in the field to achieve higher accuracy. For many 
disorders, no known pathological markers are available to confirm the diagnosis. 
Although many diagnostic tests are available, some of these, such as single photon 
emission computed tomography (SPECT) and positron emission tomography (PET), are 
expensive and invasive (National Collaborating Centre for Chronic Conditions., 2006). 
Hence, most diagnosis of movement disorders remains clinical. Clinical diagnosis is 
based on clinical features taken from examination, patient history and response to 
medication. Unfortunately, the clinical diagnosis is usually complex, subjective and 
hence, often unreliable. The accurate diagnosis of movement disorders is particularly 
difficult at the early stages. Clinical misdiagnosis rates in movement disorders is high. 
For example, in Parkinson’s Disease, it is estimated that the misdiagnosis rate remains as 
high as 25% since the 1970’s (Ali H Rajput & Rajput, 2014). About one in three patients 
with other tremor conditions were misdiagnosed as having ET, with the most frequent 
incorrect diagnoses being Parkinson’s disease and dystonia (Jain et al., 2006). This means 
that there are ET patients being treated as PD patients (and vice versa) when the prognosis 
of the two diseases are clearly different. Moreover, since there are disorders that are 
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genetically inherited (such as Huntington Disease and Wilson’s disease), the diagnosis 
has serious implications for patient’s family. Apart from that, due to their sometimes 
unusual presentations, patients with movement disorders may be diagnosed as having 
disorders caused by psychological problems (psychogenic movement disorders). More 
objective diagnosis is needed to confirm the clinical diagnosis. 
1.4 Objective diagnosis of movement disorders 
There are many potential objective assessment methods in movement disorders based on 
motor symptoms. Works include using electronic sensors to collect movement data. For 
example, using the patient’s performance in drawing an Archimedes spiral, handwriting, 
rapid alternate movement or doing an everyday task such as walking. Different 
technologies have been used in clinical settings to obtain kinematic data, such as 
digitising pads for 2D drawing data, gyroscopes for rapid alternating movements, motion 
capture using cameras and optical devices, and electromagnetic sensors for motion 
capture in 6 degrees of freedom (Allen et al., 2007; Daneault et al., 2013; D. a. Heldman 
et al., 2014; D. A. Heldman et al., 2011; Á. Jobbágy et al., 2005; Rovini et al., 2017; 
Spasojević et al., 2017; Stamatakis et al., 2013; Yokoe et al., 2009a). Using the acquired 
kinematic data, quantitative studies demonstrate that movement features belonging to 
different groups of movement disorders or healthy controls can be differentiated 
statistically. Significant features, such as speed and acceleration of movement, can be 
used to train algorithms that are able to automatically classify these groups. The 
classification task is part of what is known as predictive modelling. Predictive modelling 
is basically the process of developing a mathematical tool or model that generates an 
accurate prediction by considering relationships between the available data sets. Previous 
work has demonstrated that using machine learning methods can successfully achieve 
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high accuracy in the classification of movement disorders. However, many of these works 
focused on classifying movement disorders of patients from healthy controls as in in the 
reviews of machine learning classification of PD patients (Ahlrichs & Lawo, 2013). Yet, 
to address the problem of misdiagnosis, the real challenge is to differentiate between 
groups of different movement disorders that are commonly mistaken for each other. 
1.5 Predictive modelling of small and imbalanced data 
In a classification task, as is widely understood, the bigger the sample size, the higher the 
probability of finding a significant result. However, a large sample size is not always 
obtainable in any field of research, biomedical data included. A small sample size can be 
the consequence of research protocols, a small research population, or when it is ethically 
and morally unjustified to gather a larger sample. The number of training samples may 
also be limited because obtaining samples in a form suitable for learning may be costly 
or impractical (Weiss & Provost, 2003). Another well-known challenge in classification 
tasks is when the data in one group or class is very small compared to the other class(s). 
The problem is called an imbalanced data distribution or imbalanced dataset. There are 
many natural situations with imbalanced datasets such as analysing financial risk, 
predicting technical equipment failures, managing network intrusion and information 
filtering (He & Garcia, 2009; He & Ma, 2013). It is also common in the medical field, 
such as the occurrence of a rare disease, or newly found version of known medical 
conditions, as in case of psychogenic movement disorders. There are many machine 
learning methods tested to combat imbalanced dataset problems. Some use standard 
learning algorithms, others propose new methods to address the specific problems and 
some, combinations of the two. However, most of these solutions were tested in isolation 
usually with artificial datasets, and their solutions are not easily pertinent to the real-world 
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problems (Napierala & Stefanowski, 2016). The challenge of binary classification on 
small and imbalanced real datasets of movement disorders is yet to be tested using EAs. 
1.6 Evolutionary Algorithms 
Evolutionary algorithms (EAs) are a computational intelligence technique inspired by 
natural evolution and survival of plants and animals. There are several different types and 
versions of EAs with the major ones being genetic algorithms, evolutionary programming 
and genetic programming. EAs and genetic computation are known for their significant 
contributions to medical applications (Smith, 2011; Smith & Cagnoni, 2011). EAs have 
not only proven effective in classification tasks for medical diagnosis but offer one great 
advantage – an ability to provide “white box” analysis in which a complete description of 
how features in the data have been used to classify between the groups ( Lacy, 2015;  
Lones, Alty, et al., 2014; Lones et al., 2013). With a reliable amount of data, the 
description of these features can be generalised to inform clinical assessment and support 
clinical diagnosis (Lones et al., 2013). 
1.7 Summary 
When individuals lose the ability to move normally (along with other symptoms that 
present with movement disorders) it impacts their quality of life, as well as the people 
around them, their community and public health providers. Early and accurate diagnosis 
plays an important role in reducing the impact and prolonging a good quality of living. 
Clinical diagnosis of movement disorders are often subjective, prove to be complex and 
contribute to high rates of misdiagnosis. EAs, applied to predictive modelling using data 
from motion sensors offer an objective diagnosis of movements disorders. Additionally, 
they can give a deeper understanding of movement characteristics of different disorders 
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while performing the same motor tasks. Further analysis of the movement characteristic 
open possibilities to inform clinical assessment. However, the reality is biomedical data 
from patients are hard to obtain, time-consuming and expensive; this is true of data 
obtained from movement disorders patients as well. Furthermore, certain types of 
movement disorders, such as psychogenic movement disorders, are rare and naturally 
small in number, but need to be differentiated from their organic counterparts. Motivated 
by these challenges, the work presented in this thesis employs EAs to evolve classifiers 
that can objectively support clinical diagnosis and characterise a range of movement 
disorders. 
1.8 Hypothesis 
Based on the evidences that (1) movement disorders are common conditions with high 
global morbidity and mortality, causing a significant impact to the economy and 
negatively affecting quality of living of involved parties, (2) current clinical diagnosis of 
movement disorders is complex and largely subjective which results in a high rate of 
misdiagnosis, and (3) EAs offer great potential in objective diagnosis and characterisation 
of movement disorders, it is the hypothesized that: 
 
“Evolutionary Algorithms offer a means of differentiating and characterising a 
range of movement disorders using digitised kinematic data from common 
conventional clinical tasks.” 
 
The work in this thesis considers using kinematic data from three motor tasks taken from 
a conventional and often used clinical assessment, the Movement Disorders Society 
Unified Parkinson’s Disease Rating Scale, MDS-UPDRS namely finger tapping, hand 
opening-closing and hand-pronation-supination.  
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The objectives are to: 
 
• Apply EA predictive modelling to classify Parkinson’s disease patients from 
healthy controls, essential tremor and Huntington’s disease patients using 
available datasets. 
• Observe characteristics of different movement disorders performing the same 
motor tasks by analysing the EA classifiers evolved. 
• Use EAs to discriminate patients of functional (psychogenic) dystonia from 
healthy controls, and its organic counterpart, primary dystonia 
1.9 Thesis structure 
This thesis is organised as follows: 
This chapter provides an introduction and outline of work presented in the thesis. It also 
states the motivations, objectives and hypothesis of the research. Chapter 2 gives an 
overview of Parkinson’s disease and other movement disorders describing their history, 
anatomy, causes, main symptoms and the cognitive impairment associated with them. 
Chapter 3 provides an overview of evolutionary algorithms, examining the different 
program representations that define the different kinds of algorithm. The focus is on 
Cartesian Genetic Programming, the evolutionary algorithm chosen for this work, which 
is explained in detail in section 3.4. Chapter 4 contains a description of the motor tasks 
assessments, equipment used and the methodology used in this study. Chapter 5 presents 
results of classification and characterisation of movement features of four groups: healthy 
elderly people, PD, Huntington’s disease and essential tremor patients. Chapter 6 gives 
an overview of dystonia, describing its history, the different kinds of dystonia with their 
signs and symptoms, the cause, the diagnosis and the two kind of dystonia considered: 
24  
functional and organic dystonia. The results of classification experiments are also 
discussed. Chapter 7 presents the conclusions of the work, revisits the hypothesis and 










                                                                
Movement Disorders Conditions 
The term ‘movement disorders’ was coined in late 1960’s by Stanley Fahn and Lewis P. 
Rowland in an effort to extend a Parkinson’s disease clinic at the University of 
Pennsylvania into a clinic that also covered other movement abnormalities (Klein, 2005). 
Since then, the term has been widely used in research related to neurological problems. 
Movement disorders are neurologic syndromes that show excess of movement or a 
paucity of voluntary and automatic movements, but not related to muscle weakness or 
spasticity (Fahn, 2011). However, the disorders that were included under this term are 
characterised by many other complex signs and symptoms (Fernandez et al., 2015). 
Historically, whereas the nineteenth century can be viewed as the century that established 
neurology as a speciality in medicine, the twentieth century,specifically the second half, 
marked the evolution of movement disorders as a distinct domain (Goetz et al., 2001). 
Although many conditions that are today known as movement disorders had already been 
discovered since the last century, it is only in late 1960’s that the field of movement 
disorders was born. It was started with observations and efforts by C. David Marsden and 
Stanley Fahn (Goetz et al., 2001). In the beginning, the classification of the disorders was 
according to localisation of anatomical parts of body where the movement was affected. 
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Since then, other classifications were introduced, such as according to aetiology (causes), 
phenomenology (experience), and pathophysiology (Fahn, 2011). Perhaps the modern 
classification that is most accepted is the one developed and updated by Marsden, Fahn 
and Jankovic, published in Fahn et al. (2011). In this classification, the two major groups 
are the hypokinesias and the hyperkinesias. Hypokinesia conditions are where the 
movement is slower than normal, and hyperkinesia is the opposite. Other modes of 
classification are by clinical criteria such as age of onset and response to treatment, by 
post-mortem criteria such as presence of Lewy bodies in PD patients, and by 
genetic/molecular criteria such as a defect in protein function (Klein 2005). 
 
Table 2.1 : Classification of movement disorders based on speed of the abnormal movements. Content of 
the table from (Fahn et al., 2011) 
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2.1 Parkinson’s Disease 
Parkinsonism syndrome or Parkinsonism is a group of neurological conditions that share 
common symptoms clinically defined by the presence of certain motor features; tremor 
at rest, rigidity, bradykinesia, and gait and postural abnormalities. Parkinson’s disease 
(PD) is the idiopathic version of this syndrome where a person slowly develops difficulty 
with the control of movements without any known cause or confirmed risk factors. Simple 
daily activities such as walking and reaching for an object become challenging. 
Parkinson’s disease is chronic and progressively worsening over time. The difficulties are 
largely caused by loss of dopamine-generating neurones in a part of the brain called the 
Substantia Nigra. Both motor and non-motor deficits caused by Parkinson’s disease 
substantially impact on a person’s quality of life (Martinez-Martin et al., 2011). Although 
Parkinson’s disease is one of the most well-researched movement disorders it does not 
bring us closer to a complete understanding of this complex disease. Significant progress 
has been made in the treatment of PD motor symptoms, though the mechanisms 
underlying treatment success are often not well understood (Sulzer et al., 2015). 
Parkinson’s disease cannot be confirmed while the patient is alive. The diagnosis can only 
be made with certainty during post mortem. Low diagnostic accuracies have been linked 
to PD for more than 20 years where autopsies revealed about 25% of patients with PD as 
final clinical diagnosis did not meet required pathological markers (Ali H Rajput & 
Rajput, 2014). 
2.1.1 Signs and Symptoms of Parkinson’s disease 
There are four main signs of Parkinson’s disease: resting tremor, rigidity, bradykinesia 




Tremor is a rhythmic, involuntary shaking of a part of the body. Rest tremor is the most 
common and easily recognised symptom of PD. It is obvious when the affected body part 
is supported against gravity (and is often absent or disappears during voluntary 
movement). The frequency of the rest tremor is between 4 and 6 Hz, and usually initially 
showing in one hand or foot without any regular pattern (Stanley Fahn et al., 2011). The 
term ‘‘unilateral onset’’ is used to describe the usual pattern of onset in Parkinson’s 
disease, meaning that the rest tremor begins on one side of the body and in one limb. 
 
Rigidity 
Rigidity is an increase in resistance to passive movements that occurs in the limbs. For 
any movement to happen, there needs to be a pattern of contraction and relaxation of 
muscles. Contraction is stimulated by signals from brain that prompts the movement of 
the muscle, whereas relaxation follows when the signals end, and the muscle eases back 
to its natural state. Rigidity in Parkinson’s disease develops when the natural contraction 
and relaxation of opposing muscles fails to take place, caused by the failure of the brain 
signals to trigger the muscle movement. 
 
Bradykinesia 
The term akinesia literally means absence of movement; bradykinesia, meaning slowness; 
and hypokinesia, meaning decreased amplitude; are all used interchangeably to describe 
the most prominent phenomena of Parkinsonism. The conditions they describe are usually 
referred to collectively as bradykinesia (Figure 2.1). The complex nature of Bradykinesia 
itself is one of the reasons that make it difficult for clinicians or neurologists to be certain 
of its existence at an early stage of Parkinson’s disease. Clinicians look for signs of 
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bradykinesia by observing a patient’s ability to perform rapid, repetitive, alternating 
movements of the hand such as finger taps, hand grips and hand pronation– supination 
(Jankovic, 2008). 
 




Postural instability is the inability of a person to maintain posture and balance caused by 
impaired postural reflexes. People with Parkinson’s disease tend to fall backward, 
although falls are unusual in the early stages. Postural instability can be present even at 
diagnosis in some patients but when prominent in early stages of the disease it should 
suggest the possibility of an atypical parkinsonian disorder, such as progressive 
supranuclear palsy (Egerton et al., 2012). A normal individual should be able to recover 
balance spontaneously with a quick backward step, but patients with PD often take several 
steps to recover balance and may even fall if not caught in time. Although the four main 
symptoms described above are the most well-known signs of PD, several secondary signs 
and symptoms, including non-motors symptoms, have been detected. Note that not 
everyone with Parkinson’s disease develops the same symptoms. Other reported 
symptoms include masked facies (loss of facial expression and a decreased rate of eye 
blinking), speech deficits, dysphagia (difficulty in swallowing), drooling, gastrointestinal 
complications, micrographia (handwriting becomes small because of difficulty with fine
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motor movement), disturbance of the spatiotemporal aspects of gait, sleep disorders, and 
mood fluctuations. Non-motor symptom such as depression is the most common 
psychological problem in Parkinson’s disease (Sharma, 2008). These symptoms will 
eventually severely impair patients of PD quality of life such as shown in advanced 
Parkinson’s disease patients. 
2.1.2 The anatomy of Parkinson’s Disease 
In the 1960s, scientists discovered that deficiency of a compound named dopamine in the 
specific part of the brain called basal ganglia is at the root of Parkinson’s disease 
(Hornykiewicz, 2006). The basal ganglia refers to a group of structures linked to the 
thalamus in the base of the brain and involved in coordination of movement. Parkinson’s 
disease is associated with damage to the basal ganglia and has several distinct outward 
symptoms. 
Symptoms of Parkinson’s disease are caused by the death of neural cells in one of 
the nuclei (group of neurons) of the basal ganglia called the Substantia nigra; the cause of 
the cell death is unknown. The Substantia nigra naturally produces a neurotransmitter 
(chemical messenger) called dopamine that helps in the transmission of signals in the 
















Figure 2.2: Location of the substantia nigra within the basal ganglia (Figure from https://en.wikiversity.org) 
 
 
As the disease progresses and less dopamine is delivered, outgoing signals become 
undependable and movements become irregular and uncontrolled. Figure 2.3 shows a 





Figure 2.3: Pigmentation loss in the substantia nigra a) Normal b) Parkinsonian midbrain showing a 
characteristic of pigmentation loss in the substantia nigra (arrowed). Micrographs of the substantia nigra 
reveal c) normal pigmented neurons in normal brain and d) the loss of pigmented neurons in a brain affected 
by Parkinson’s disease. Figure from Chaudhuri & Ondo (2009). 
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Apart from the cell loss in the Substantia nigra, pathological changes of PD also include 
the presence of Lewy Bodies (LBs) in surviving cells. Lewy bodies are abnormal masses 
of protein that develop inside nerve cells found in PD and occur in all areas of neuronal 
degeneration. Although LBs are a pathological hallmark of idiopathic PD, unfortunately, 
they are not unique to PD; other conditions in which they may be seen in degenerating 
neurons include corticobasal degeneration, progressive supranuclear palsy, motor 
neurone disease, ataxia telangiectasia and Hallevorden-Spattz disease (Gibb & Lees, 
1988), classic Pick’s disease, argyrophilic grain disease, Alzheimer’s disease, and 
dementia with Lewy bodies (Popescu et al., 2004). 
 
 
Figure 2.4: Lewy bodies presence in neurological conditions LBs are numerous in the amygdala in 
Alzheimer disease (A), dementia with LB (B), and classic Pick ‘s disease (C). Figure from Popescu et al., 
(2004). 
 
Other than pathological overlap with these diseases, PD also shares some clinical features 
with a number of other neurodegenerative conditions which make it even difficult for a 
clear-cut diagnosis. Conditions showing similar symptoms as PD are discussed further in 
Section 2.1.6. The success of determining what is happening to PD patients still leaves us 
puzzling what cause it to happen. The idiopathic nature of PD means that scientists still 
cannot comprehend what is actually causing the loss of neurons cells and presence of LBs 
in affected areas of the brain. Research is ongoing to find out possible causes of PD and 
who the people are that have a higher chance of developing the disease. 
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2.1.3 The diagnosis of Parkinson’s Disease 
As for most movement disorders, the diagnosis of Parkinson’s disease is a ‘clinical’ 
diagnosis since the methodology depends heavily on the observation for manifestations 
of the Parkinsonism symptoms and history taking of the subject by the neurologist or 
other qualified medical practitioners (National Collaborating Centre for Chronic 
Conditions., 2006). In the face of huge resources devoted to learn more about Parkinson’s 
disease, there are still no laboratory tests such as a tissue diagnostic or other conclusive 
biomarkers test that can confirm the diagnosis of Parkinson’s disease while a patient is 
alive. 
2.1.4 Clinical assessment of Parkinson’s disease 
Demonstration of Parkinsonism requires evidence of bradykinesia and at least one of the 
other cardinal features: tremor at rest, rigidity and postural instability. These criteria have 
been summarised in the UK Parkinson’s Disease Society Brain Bank Criteria (UKBBDC) 
(Gibb & Lees, 1988). UKBBDC is the most widely accepted clinical criteria for the 
diagnosis of PD and may improve clinicopathological correlation when strictly applied 
(Hughes et al., 2001). There are many scales that have been developed for the purpose of 
quantifying the severity of PD. There are scales to assess PD manifestation (impairment), 
disability, and scales that assess impairment and disability (Perlmutter, 2010). Table 2.2 
summarise the scales. Among these scales, the Unified Parkinson’s Disease Rating Scale 
(UPDRS) has been the most accepted and popular rating scale (Martinez-Martin et al., 
1994). However, several highlighted limitations of UPDRS (Hilten et al., 1994; 
Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease, 2003) 
have led to a new revised version of UPDRS by the Movement Disorders Society: MDS-
UPDRS (Goetz et al., 2008) 
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• Webster Scale 
• Columbia University Rating Scale 
• PD Impairment Scale 
Disability 
• Hoehn & Yahr 




Motor symptoms & disability 
• UPDRS, MDS-UPDRS 
• New York University Scale 
• Short PD Evaluation Scale 





The Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease 
Rating Scale (MDS-UPDRS) has four sections: 
 
Part I: non-motor experiences of daily living  
Part II: motor experiences of daily living  
Part III: motor examination, and 
Part IV: motor complications. 
 
In each part, there are items that assess different parts of PD. This rating scale evaluates 
the severity of PD symptoms in a 5-point scoring system, 0 for no symptom and 4 for a 
marked severity of the symptom. Items from parts I, II and IV are rated by the patient 
themselves, either by filling in the questionnaire or by answering questions (from the 
scale) from the clinicians. Part III items are rated by clinicians, through observation and 
motor examination. In part III, instructions are given on motor tasks to be executed by 
patients and guides for clinicians on how to rate the performance. The full MDS-UPDRS 
scale is provided in Appendix A of this thesis. Examinations by clinicians comprise items 
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to test symptoms such as rigidity, speech impairments and leg agility. Motor tasks include 
finger tapping, hand movements (opening-closing), pronation-supination movement of 
hands, toe-tapping and gait testing. 
Part III of the scales (UPDRS and MDS-UPDRS) have been tested and proven to 
provide good quality of measurements (Goetz & Stebbins, 2004; Goetz et al., 2008). 
However, there is no confirmation on how strictly the criteria in any guide are followed 
during the diagnosis process. The clinical diagnosis is considered as not definitive. The 
gold standard for definitive diagnosis of PD is pathologic findings which is neuronal loss 
in substantia nigra and present of Lewy bodies in the brain of patient. This confirmation 
is done during autopsy. Comparison has been made between clinical diagnosis and 
findings of autopsy on PD patients to determine the diagnostic accuracy of Parkinson’s 
disease. 
2.1.5 Measurement of diagnostic accuracy 
Accurate diagnosis is very important in medicine, usually determining what additional 
diagnostic tests are needed, help in choosing more targeted, effective and often less 
invasive treatments or interventions, to eventually improve patient care management and 
reduce healthcare costs. The accuracy of a diagnosis is measured by comparing the test 
results to the true condition status of the patient or the gold standard. In case of PD, the 
gold standard is autopsy report of the patient. Two basic measures of diagnostic accuracy 
are sensitivity and specificity. Their definitions are best illustrated by a table with 2 rows 




If n is number of individuals studied, then a + c individuals have the disease. Of the a + c 
individuals who have the disease, a have positive test results (true positives, TP) and c 
negative have test results (false negatives, FN). Of the b + d individuals who do not have 
the disease, d have negative test results (true negatives, TN) and b have positive test 
results (false positives, FP). 
Sensitivity is the proportion of individuals with the disease who are correctly identified 
by the test. A test that is able to detect all the individuals with disease is said as having 






Specificity is proportion of individuals without the disease who are correctly identified 
by the test, calculated as following: 
 
 
A test with 100% specificity will detect all the healthy individuals and give a negative 
result to them (negative of having the disease). The best test would be one that has a 
                                                        Table 2.3: Table of frequencies 
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sensitivity and specificity that are both as close to 1 (or 100%) as possible. However, in 
practice, sensitivity may be gained at the expense of specificity, and vice versa. Whether 
the aim is for a high sensitivity or high specificity depends on the condition or disease, 
also what the consequences of FN or FP test result on the individuals tested are. For 
conditions that are easily treatable, high sensitivity is preferable; for those that are serious 
and untreatable, high specificity is important to avoid making a false positive diagnosis 
(Petrie & Sabin, 2000). In the case of Parkinson’s disease, false positive diagnosis results 
in the unnecessary administration of drugs, a false negative diagnosis delays the initiation 
of drug therapy or other types of therapies. 
Another way diagnostic accuracy is commonly described are predictive values 
which highlights the consequences associated with the test results. These predictive 
values provide information about how likely it is that the individual is correctly 
diagnosed. Positive predictive value (PPV) is the proportion of individuals with a positive 
test result who have the disease. Negative predictive value (NPV) is proportion of 
individuals with a negative test result who do not have the disease. These values can be 









Predictive values are dependent on how common the disease in the population is being 
studied or the disease prevalence. In populations where the disease is rare, the NPV value 
will be much lower than in populations where the disease is common and vice versa. In 
certain cases, there are needs to make a diagnosis on the basis of a continuous 
measurement. It means that there is no certain definitive threshold above (or below) that 
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implies the disease is positively detected. In these cases, the upper (or lower) limit of the 
reference interval can be used. A cut-off value choice will change its related sensitivity, 
specificity and predictive values. The objective is to choose a cut-off value that will 
optimise these measures as desired. 
2.1.6 Differential diagnosis of Parkinson’s disease 
The low diagnostic accuracy is one of the issues that have been associated with 
Parkinson’s disease for years. The accuracy rates were observed by comparing final 
clinical diagnosis of a patient to autopsy result on brain matters. This type of study is 
known as clinicopathological. Perhaps the first significant clinicopathological study that 
presented a quite shocking result about the diagnostic accuracy of Parkinson’s disease 
was published in 1991. In  Rajput et al.(1991) , autopsy was performed on 65 patients, 41 
of them having PD as a final clinical diagnosis after an average of 11.7 (range 2 -39) years 
of illness. A 22 year study by Rajput et al. (1991) found out that out of the 41 patients, 
Lewy bodies’ presence was detected in only 31 of them which indicated only a 76% rate 
of diagnostic accuracy. Soon later, another clinicopathological study with a bigger 
number of subjects was published; the study on 100 cases of clinically diagnosed PD 
shown same rate of accuracy at 76% (Hughes et al., 1992). In contrast, very high 
percentages of diagnostic accuracy (99%) have been reported in tertiary hospitals by 
movement disorder specialists (Hughes et al., 2002). It was speculated that the higher 
accuracy may be due different methodology (Rajput & Rajput, 2014) or the fact that 
patients were evaluated by specialist neurologist in a specialist movement disorder 
service. This may have been proven by a later study by Joutsa et al. (2014) that 
investigated diagnostic accuracy of parkinsonism syndromes by general neurologists in 
Finland. Only 58 (75.3%) of the 77 patients that had been diagnosed as Parkinson’s 
disease (PD) were confirmed after the neuropathological examination. Another recent 
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study by Adler et al. ( 2014) reports results of diagnostic accuracy of an ongoing clinical- 
neuropathologic research. Taking into account all PD patients examined in this study, the 
final clinical diagnosis of PD is accurate in only 77% of the subjects. It can be seen that 
both studies, Adler et al.(2014) and Joutsa et al.( 2014) showed percentage of diagnosis 
accuracies remarkably similar with 1990’s studies, indicating that PD is still facing 
serious problems in this area. It is rather sobering that there is no marked improvement in 
accuracy of diagnosis since more than 20 years ago (Ali H Rajput & Rajput, 2014). 
Diagnostic inaccuracy can cause patients to receive treatment as PD patients up 
to their demise when they actually had other Parkinsonism syndromes with similar 
features with PD. There are many possible answers to low diagnostic accuracy of 
Parkinson’s disease. One possibility is the difficulty of rejecting other Parkinsonism 
conditions with the different degrees of overlap especially in the early course of the 
disease. Parkinsonism is an umbrella term used to describe many conditions that share the 
main symptoms of slow movement, sometimes with tremor, rigidity and problems with 
walking. A variety of conditions may cause Parkinsonism syndromes (also called 
Parkinsonian) independent of the idiopathic loss of substantia nigra neurons; these include 
degenerative conditions, drug-induced and several other types of movement disorders. 
Several conditions that have been misdiagnose as PD include Alzheimer’s disease, 
progressive supranuclear palsy, multiple system atrophy, dementia with Lewy bodies, 
corticobasal ganglionic degeneration, vascular Parkinsonism (Adler et al., 2014; Hughes 
et al., 2002; Joutsa et al., 2014) and drug-induced parkinsonism (Rajput et al., 1991). 
Apart from Alzheimer’s disease, they are all rarer than PD but may be clinically indistinct 
in the early stages of disease. 
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Multiple system atrophy (MSA) 
Multiple system atrophy, MSA is a condition often confused with Parkinson’s disease 
because of its Parkinsonism symptoms. There is up to 55% of cases where MSA patients 
die with PD as final clinical diagnosis (Quinn, 2005). Two variants of MSA are MSA-P 
and MSA-C. “P” in the first variant is for parkinsonian where there is predominating 
Parkinson’s –like symptoms, and clinically the MSA-P phenotype presents the most 
difficulty in differentiating it from Parkinson’s disease (Chaudhuri & Ondo, 2009). 
The parkinsonian features of MSA include progressive bradykinesia, which is usually 
symmetrical, rigidity and postural instability. MSA-C is a cerebellar dysfunction variant 
and characterised by progressive ataxia (an inability to coordinate voluntary muscular 
movements) of the gait and arms and dysarthria (difficulty in pronouncing words). 
Compared to PD, autonomic failure in the form of sympathetic dysfunction occurs early 
and more severe in MSA. Genitourinary problems such as erectile failure and urinary 
symptoms are also common in MSA. In contrast to PD, it is also unusual for a patient 
with MSA to develop dementia or hallucinations. 
 
Progressive Supranuclear Palsy (PSP) 
PSP is also known as Steele-Richardson-Olszewski syndrome. PSP can have a wide 
clinical spectrum, with different clinical variants. Classic PSP variant is characterised by 
supranuclear gaze palsy (predominantly vertical gaze), Parkinsonism, pseudobulbar 
affect, prominent frontal lobe syndrome, axial symptoms (neck and trunk) with early falls 
in the first year after onset, and symmetric symptoms. Resting tremor is uncommon. Gait 
is broad-based and unsteady, unlike the typical small-stepped shuffling gait in PD, with 
the typical “surprised” facies, spastic dysarthria, and retrocollis. Parkinsonian variant has 
parkinsonian features very similar to those seen in PD or MSA, but without much 
response to levodopa and a predominance of postural instability and gait dysfunction 
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(Fernandez et al., 2014). Even with strict clinical diagnostic criteria applied, autopsy 
revealed 22% of patients with PSP as final clinical diagnosis turned out to be PD patients 
(Respondek et al., 2013). 
 
Dementia with Lewy bodies (DLB) 
DLB is characterised by early onset progressive dementia with behavioural abnormalities 
that may interfere with normal social and occupational function, visual hallucinations, 
visual defects fluctuation in cognition and attention, even psychosis in the drug-naive 
state and Parkinsonism. DLB is very difficult to differentiate from PD dementia because 
patients with either condition can exhibit fluctuations in alertness, frequent falls, 
hallucinations, and sensitivity to PD medications (Fernandez et al., 2014). During 
autopsy, cases of DLB cannot be differentiated from cases of dementia occurring late in 
Parkinson’s disease (Chaudhuri & Ondo, 2009). 
 
Corticobasal Ganglionic Degeneration (CBD) 
CBD is a slowly progressive rare condition with patients aged 60’s to 70’s. Unilateral 
development of tremor, apraxia and rigidity in an upper limb are among the first 
symptoms shown. Patients then develop progressive gait disturbances, cortical sensory 
loss, motor apraxia and stimulus-sensitive myoclonus, which results in a jerky, 
uncontrollable hands. In 50% of patients, a jerky, uncontrollable movement called alien 
limb phenomenon may have occurred. Along the course of the disease, the condition 
becomes bilateral with progressive cognitive impairment. Patients do not respond to 




Alzheimer’s disease is the most common progressive late-onset disorder. It is a 
degenerative condition that leads to a condition called dementia. Dementia is a general 
term used to describe the loss of memory and mental abilities severe enough to affect 
daily life. Sixty to eighty per cent of all dementias are Alzheimer’s disease cases that 
make it the most common type of dementia. With progressive loss of memory as its main 
feature, there are cases where it is mistaken as Parkinson’s disease, especially PD with 
dementia variant (Adler et al., 2014; Joutsa et al., 2014). 
 
Vascular Parkinsonism 
Vascular Parkinsonism symptoms include rest tremor, bradykinesia, rigidity and postural 
instability but unlike in Parkinson’s disease, the motor symptoms are usually bilateral. 
Most patients have predominant lower-extremity symptoms, such as a gait disturbance 
(freezing, gait initiation failure, turning difficulties), with minimal upper-extremity 
symptoms, or walk with small steps. These common features might make it challenging 
to differentiate the condition with Parkinson’s disease that showing postural instability 
and gait difficulty (Chaudhuri & Ondo, 2009). 
 
Drug-induced Parkinsonism (DIP) 
Dopamine receptor-blocking antipsychotic drugs such as thioridazine, chlorpromazine 
and haloperidol commonly known to cause Parkinsonism, although any kind medication 
have a potential of doing so. Due to many overlaps of clinical features such as rigidity, 
bradykinesia, tremor and gait disturbance, Drug-induced parkinsonism may be 
misdiagnosed as Parkinson’s Disease. Although DIP symptoms are usually more bilateral 
or symmetrical compared to PD and might have a slightly faster tremor, symptoms 
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between the two diseases are almost impossible to be clinically distinguished (Chaudhuri 
& Ondo, 2009). 
2.2 Huntington Disease 
Huntington’s disease (HD) is a genetically inherited neurodegenerative disease, resulting 
in death within 15 to 20 years after diagnosis. The prevalence of diagnosed HD in the UK 
has doubled between 1990 and 2010. By extrapolation, it is estimated that there are more 
than 5700 diagnosed adult HD patients in UK (Evans et al., 2013). Huntington's disease 
has autosomal dominant inheritance. In this type of inheritance pattern, each children of 
an affected individual have a 50% risk of inheriting the disorder. Individuals at-risk are 
not gender dependent and it does not skip generations (Figure 2.5). Apart from apparent 
effects to quality of life of patients, the fact of dominant inheritance touches entire 
families: at-risk individuals and even genetically normal family members. 
 
 
Figure 2.5: Chart redraw from Bates et al. (2002) to show autosomal dominant transmission in HD. 
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The accepted clinical feature of HD are psychiatric abnormalities, cognitive decline and 
movement disorders (Bates et al., 2002). Early signs and symptoms can include 
irritability, depression, small involuntary movements, poor coordination, and trouble 
learning new information or making decisions. As the disease advanced, these signs 
become more noticeable. Psychiatric abnormalities include changes in personality such 
as depression, anxiety, apathy, obsessive-compulsive behaviours, outbursts, addictions, 
and occasionally psychosis (Dayalu, 2015) . Cognitive decline in many cases ends up as 
dementia. Although many signs of behavioural changes might be shown at early stages 
of HD, motor signs are still the best indication for diagnosis. 
2.2.1 Bradykinesia in Huntington’s disease 
The most well-known neurological feature of HD is the movement disorder chorea, an 
involuntary movement produced by jerk-like contractions of muscles that move randomly 
from one part of the body to another (Albanese et al., 2013). Chorea is characterised by 
excessive spontaneous movements that are irregularly timed, non-repetitive and abrupt. 
Other movement disorders include rigidity, slow or abnormal eye movements, impaired 
gait, posture and balance, and difficulty with the physical production of speech or 
swallowing. Progressive motor failure is a major cause of life-ending complications. 
Bradykinesia also exists in HD. Although HD is characterised by chorea, a hyperkinetic 
disorder, studies shown that it can co-exist with bradykinesia. In fact, in Garcia Ruiz et 
al. (2000), not only HD patients were slower than controls; they were even slower than 
PD patients of matching ages. A follow-up study of 76 HD patients found that 
bradykinesia was already evident in early stages and increased linearly with increasing 
disease stage (van Vugt et al., 2004). On the contrary, other studies challenged the 
findings and suggest that bradykinesia is not a feature of movement disturbance in HD. 
Rather, it was suggested that slowness of movement, when observed in HD, is a result of 
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compensatory adjustments in velocity to improve accuracy in the presence of choleric 
intrusions (Duval et al., n.d.; Fenney et al., 2008). It raises the question of whether 
bradykinetic features found in HD share the same characteristics shown by PD patients 
or healthy people of old age. 
2.3 Essential tremor 
Tremor is a rhythmic, oscillatory movement produced by alternating or synchronous 
contractions of antagonist muscles (S. Fahn et al., 2007). It is the most common 
involuntary movements humans can experience. There are many ways to categorise 
tremor. Phenomenologically, it can be divided into two, action tremor and rest tremor. 
Action tremor is recognised  when muscles are in use voluntarily. It is the opposite of rest 
tremor, which is one of the main symptoms of PD. Rest tremor is the type of tremor 
detected when the muscles are not in action. Action tremor is the main characteristic of 
Essential Tremor (ET), one of the most common neurological conditions. ET is chronic 
and progressive, and although once known as merely a motor disorder but psychological 
complications are now recognised as part of the features of this condition. ET is linked to 
degeneration of neurons in the cerebellum which is, like the basal ganglia (where 
movement disorders in PD start), also plays important roles in motor functions. Although 
patients of these two conditions experience different kinds of movements disorders, they 
have been mistaken for each other many times. A study disclosed that 30% of patients 
that were diagnosed as having ET were, in fact, having other conditions where most of 
them should be diagnosed as PD patients (Jain et al., 2006). The other way, in PD 
diagnosis, ET was one of the most common causes of misdiagnoses. The relationship 
between ET and PD always been a great interest in movement disorders research 
(Berkhout, 2015; Geraghty et al., 1985;  Jiménez-Jiménez et al., 2012; Shahed & Jankovic, 
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2016). This is especially with findings of Lewy bodies in brain matter of ET patients 
suggesting the possibility that ET is also a neurodegenerative disease. That ET is also a 
type of disease that progress with the death of certain neurons, a major debate related to 
the topic of connection between ET and PD is whether ET is a risk-factor of PD (Benito-
León, 2014; Louis et al., 2016). Even though the main similarity between PD and ET is the 
tremor itself, another main symptom of PD, bradykinesia, also exists in ET. This was 
reported in Duval et al. (2006) and a recent study by Goubault et al.(2017). Duval and 
Goubault used ET patients recorded movements of executing rapid alternate movements 
(pronation-supination) to make objective assessment. Prior to Duval, other research also 
detected a level of bradykinesia in ET patients that was comparable to mild symptoms of 
PD patients (Montgomery et al., 2000). Then, the idea was challenged by another study 
by Özekmekçi (2005) that found no significant difference of time taken to push 
microswitches between ET patients and healthy controls. Interestingly, they found 
slight prolong in ET patients, but concluded that the delay was due to the patient’s effort 
to control the tremor in executing the task. 
With all the controversies about the connections between ET and PD, until 
recently, no conclusions have been made and we are still far from learning the true nature 
of the relationship between these two disorders, if any (Algarni & Fasano, 2018). More 
methods of objective assessments are needed to confirm previous findings. 
 
2.4 Objective assessment of Bradykinesia in movement disorders 
Bradykinesia might have the highest potential as a motor progression marker of 
Parkinson’s disease (Maetzler et al., 2009). As it is the only clinical sign that is 
compulsory for diagnosis, this may also contribute to current high diagnostic inaccuracy 
of Parkinson’s disease (Bajaj et al., 2010). There are many potential objective methods to 
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assess bradykinesia in movement disorders. Research has previously used patient’s 
digitised performance in drawing the Archimedes spiral, handwriting, rapid alternate 
movement, finger tapping or doing an everyday task such as walking. Different 
technologies have been used in clinical settings; for example, wearable sensors to obtain 
kinematic data such as digitising pads for 2D drawing data, a gyroscope for rapid 
alternating movements, motion capture cameras and optical devices, as well as 
electromagnetic sensors for motion in 6 degrees of freedom (Allen et al., 2007; Daneault 
et al., 2013; Heldman et al., 2014; Heldman et al., 2011; Jobbágy et al., 2005; Rovini et 
al., 2017; Spasojević et al., 2017; Stamatakis et al., 2013; Yokoe et al., 2009a). In these 
studies, movement features were extracted from the recorded data. Features such as 
movement times, speed, rhythm, reaction times and frequencies can be used to describe 
the structure of the data or make inference by comparing the movement features of 
involved groups. Popular statistical tests were used for comparison between groups of 
movement disorders and healthy controls, to look for the difference between the means 
or standard deviation of variables. Examples of common tests are the t-test and ANOVA 
for normally distributed data; Wilcoxon rank tests or sign test for data that does not meet 
statistical assumptions required for parametric tests. 
In differentiating PD patients from healthy controls, several features of finger 
tapping movement have shown a marked difference between the two groups. Example of 
said features are finger-tapping test score (Jobbágy et al., 2005), maximum opening 
velocity and total distance of finger-tapping movement (Yokoe et al., 2009b), index for 
decrementing frequency, index for augmenting frequency, number of hesitations and 
number of halts (Stamatakis et al., 2013). Using other motor tasks, Daneault et al.(2013) 
found that maximum velocity of pronation-supination task correlated well with UPDRS 
clinician’s score. Other useful features extracted in diadochokinetic movements studies 
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that involve hand pronation-supination can be found in Okada & Okada (1983) and 
Jiménez-Jiménez et al. (2010). 
Other than PD patients, similar studies have been conducted on other movement 
disorders such as Huntington Disease (Garcia Ruiz et al., 2000; Künig & Alba, 2011; 
Mann et al., 2012; Martínez Pueyo et al., 2016; Müller et al., 2013; Thompson et al., 1988) 
and essential tremor (Duval et al., 2006; Jiménez-Jiménez et al., 2010; Kwon et al., 2016). 
From these studies, many important movement features have been extracted and proven 
as significant features in differentiating the groups. However, statistical analysis is usually 
focused on understanding the data (descriptive statistics) and making statements about 
the analysis of in-hand data (inference). Statistical techniques can be used in the prediction 
of unseen data points, but the performance is usually not optimum for complex, non-linear 
problems. Hence, the use of machine learning techniques which have been shown to 
classify unseen data, without prior assumptions about its statistical properties. 
2.5 Machine learning in movement disorders 
The significant features such as speed and acceleration of movement can be used to train 
classifiers that able to classify different groups automatically. The classification task is 
part of what is known as predictive modelling. Predictive modelling is basically the 
process of developing a mathematical tool or model that generates an accurate prediction 
by considering relationships between available data. Predictive modelling is commonly 
divided into two categories depending on type of the predicted data. To predict a 
continuous value a regression model is used, classification models are used when the 
response are in form of a categorical variable. There are many studies that have employed 
machine learning on PD patients’ data to evolve classifiers. For example, in Deløcan et 
al., (2011), several types of Evolutionary Algorithm-Based Neural Networks were used 
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on a PD dataset taken from repository. In Spadoto et al.(2011), a classification task used 
an Optimum-Path Forest (OPF) on available PD features of Oxford Parkinson’s Disease 
Detection Dataset. Apart from for classification task to detect PD, machine learning was 
also used to assess inter-rater agreement of motor task assessment. Martinez-Manzanera 
et al. (2015) used the popular machine learning method, Support Vector Machine (SVM) 
to check on inter-rater agreement of Bradykinesia items in MDS-UPDRS. The data in this 
study was collected using orientation sensors while PD patients performed finger tapping, 
diadochokinesis (pronation-supination) and toe-tapping. A similar study was conducted 
by Patel et al. (2009), also using SVM but the data was collected using accelerometers. 
Naive Bayes and Optimum-Path Forest were used on handwriting and spiral drawing data 
in Pereira et al.(2015). A review paper by Ahlrichs & Lawo (2013) listed many other 
studies that employed machine learning methods for automatic detection of PD motor 
symptoms. However, many of these works focused on classifying movement disorders 
patients from healthy controls. Whereas, to address the problem of misdiagnosis, the real 
challenge is to differentiate between groups of different movement disorders that 
commonly mistaken for each other. 
2.6 Conclusions 
As discussed in this chapter, bradykinesia is the only physical sign that is obligatory for 
diagnosis of PD. It is a complex clinical sign that comprises several abnormalities of 
movement including delayed initiation, reduced amplitude, reduced speed, impaired 
rhythmicity, and decrementing speed and amplitude. The phenomenology of the 
components of bradykinesia remain incompletely understood. This means that it can be 
very difficult to clinically ascertain whether bradykinesia is definitely present or not when 
a patient presents with only some of the components of bradykinesia, with very subtle 
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abnormalities or when other abnormal movements such as tremor are also present. 
Bradykinesia also exits in Huntington disease despite the fact that its main feature is 
chorea, a hyperkinetic movement. However, there are suggestions that the slowness in 
HD is not a feature, just an effort to mask other movement problems. The same goes for 
ET, bradykinesia was detected in a few studies but challenged by others. There is a 
question whether bradykinesia exists in HD and ET, and if it does, does it have the same 
characteristics with bradykinesia in PD? At the heart of this problem is uncertainty about 
the true nature of bradykinesia and its distinguishing characteristics. A better 
understanding of the characteristics of bradykinesia and how it differs between these 
groups can be used to inform clinical assessments towards conforming early diagnosis. 
Quantitative studies (using statistical analysis of recorded data) have proven it can be 
used to help objective assessment of bradykinesia and other signs of movement disorders. 
Statistical techniques are not often used in quantitative studies as the problems are often 
complex and non-linear, leading to poor performance in describing and making inferences 
about the data collected. The selection of motor tasks in previous quantitative studies 
rarely mirror the standard motor tasks used in conventional clinical assessment. 
Therefore, it is proposed that in supporting the diagnosis of movement disorders and to 
inform clinical assessment, machine learning methods applied to movement data acquired 
from standard clinically accepted motor tasks, such as the Movement Disorders Society 
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), is an optimal approach to 
providing an effective and practical approach to diagnosing Parkinson’s disease and 














                                                                    
Machine Learning 
Machine Learning  is a field that has been growing in popularity for more than 30 years. 
It has taken inspiration from many aspects of human nature and biology in various ways. 
The biggest impact of machine learning has included applications in finance, information 
technologies, decision-making, healthcare, manufacturing and securities, to name a few 
(Paliouras et al., 2003). Machine Learning is often considered to be a part of artificial 
intelligence where computer algorithms learn by itself from data and information. It then 
uses information gathered from the learning process to autonomously identify underlying 
patterns in a dataset to describe the data and also make prediction based on the given 
pattern. The capability to produce sensible outputs for new inputs that were unseen during 
learning (the ability to generalise) is the main advantage of machine learning, especially 
compared to traditional statistical analysis. Textbooks usually categorise machine 
learning algorithms based on their learning methods. Marsland (2015) classifies Machine 
Learning algorithms into four types: supervised learning, unsupervised learning, 
reinforcement learning and evolutionary learning (Table 3.1). In this thesis, only two 
types of learning algorithms were applied, supervised learning and evolutionary learning 
(evolutionary algorithm). 
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3.1 Supervised learning 
The most common type of learning is supervised learning; many real-life applications 
were based on this type of learning. In any learning algorithm, a set of data is used as the 
training data. In supervised learning, the training data consists of a set of input data that 






When an underlying function from inputs to outputs exists, it is referred to as the target 
function. The estimate of the target function output by the learning algorithm is known as 
the solution of the learning problem. In the case of classification this function is 
sometimes referred to as the decision function. The solution is chosen from a set of 
candidate functions which map from the input space to the output domain (Cristianini & 
Shawe-Taylor, 2000). 
There is an overwhelming range of supervised learning algorithms to choose from. 
However, until now there is no ‘one algorithm fits all’ solution. Each algorithm has its 
          Table 3.1: Types of machine learning algorithms as defined by Marsland (2015). 
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advantages and disadvantages and users need to consider characteristics of the problem 
in-hand to decide on a suitable algorithm. Two types of very popular supervised learning 
algorithms, Artificial Neural Networks (ANNs) and Support Vector Machines (SVMs) 
are used in this study to provide a comparison of performance with the algorithm under 
investigation. 
 
Artificial Neural Networks (ANNs) 
ANNs are learning algorithms that base their learning on how the human brain processes 
information. ANNs learn (or are trained) through experience as in the human neural 
network, gain their knowledge by identifying the patterns and relationships in the data. 
ANNs have been used for a variety of tasks including the construction of models for 
prediction, clustering and classification. Basically, an ANN is a network of simple 
processing units called neurons. Signals or influences can only pass in one direction along 
given connection (also called arc or edge). The effect of the signal along a connection 
may be adjusted by a weight. This means that ANNs are weighted directed graphs. Each 
node processes the combination of weighted signals presented to it, in a manner that varies 
according to the type of an ANN. There are many types of ANNs, they can be 
differentiated from each other by looking at following criteria: 
i. connection topology, 
ii. basis function, 
iii. training method, and 
iv. learning algorithm. 
 




The basis function defines what processing each node carries out on the combination of 
all its inputs, in order to generate its output value. 
 
The training method is concerned with how the ANN learns. ANNs can be used in 
supervised learning environment where the ANN is provided with training data (input 
data for which the output is already known), learn from it and try to predict the correct 
output for inputs not given in the training data. It can also be used in unsupervised learning 
when the ANN is not provided with outputs, but rather, is left to uncover patterns in the 
input data without a priori information as to what these patterns may be (Brabazon et al., 
2015). The main drawback of ANNs is their black box approach towards problem solving. 
An ANN does not provide more information on how the learning problem was solved. 
Symbolic rules may be extracted from trained ANNs, but other algorithms such as genetic 
programming provides better option in this area, as it is truly white box in its operation 
providing a discrete mathematical expression describing how data inputs are used in the 
resulting classification. 
 
Support Vector Machine (SVM) 
SVMs are classification algorithms that are based on statistical learning theory. It is a 
very popular supervised learning methodology in modern machine learning and perhaps 
the most used one. It can be used for classification, regression and prediction and are 
particularly suited to binary classification, where there are only two classes to the 
problem. SVMs aim for good fitting of training data, while avoiding overfitting, so that 
the solution generalises well to new instances of data (Brabazon et al., 2015). SVMs work 
on the concept of linearly separating data into their correct classes. The linear boundaries 
between classes are generally known as hyperplanes: linear or affine subspaces of 
dimension n − 1, where n is the dimension of the space of linearly separable classes. 
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Hyperplanes can be straight line in case of 2D space (Figure 3.1) or a plane in 3-D space, 
or a 3-D space in 4-D space. A hyperplane splits the n- dimensional space into two parts, 





Figure 3.2 a) shows a simple example of a dataset that can be divided into two classes 
(labels × and +) which are not linearly separable. However, when mapped into the higher 
dimensional ‘feature space’, the classes are now linearly separable (Figure 3.2 b)) 
 
 
Figure 3.2: a) Two-class dataset that is not linearly separable. b) When the dataset i (a) transformed to 
higher dimension, it is now separable. Figure from Brabazon et al. (2015) 
 
 
Figure 3.1: Hyperplane: a line that linearly separate two-class dataset (left) compared with a nonlinearly 
separable two-class dataset (right). Figure from Brabazon et al., (2015) 
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The mapping of data into a higher dimension is known as kernelling. The kernel function 
in SVM transforms the messy pattern or input vector space to the higher dimensional 
feature space by a nonlinear mapping; the classes in the feature space may be linearly 
separable even if they were not in the original pattern space. In implementing SVMs, 
choosing an appropriate kernel function and choosing good values for its associated 
parameters is very important. 
SVMs has been implemented in many real-life applications such as text classification 
tasks, handwritten digit recognition, category assignment, detecting spam and sentiment 
analysis, among others (Hearst et al.,1998; Ma & Guo, 2014). In the medical field, it has 
been used extensively for medical image recognition and classification of diseases 
(Statnikov et al., 2011) . However, SVMs have acknowledge drawbacks (Brabazon et al., 
2015): 
i. It is difficult to incorporate domain knowledge into an SVM, other than in the data 
pre-processing or kernel selection steps. 
ii. The rationale for the resulting classification decisions can be hard to reverse- 
engineer, as the support vectors provide limited information to the modeller. 
iii. SVMs were originally designed to work with real-valued vectors, so there is no 
unique way to incorporate noncontinuous data (for example, categorical data) into 
an SVM. 
iv. The SVM methodology also requires that data vectors be scaled, and different 





3.2 Evolutionary Algorithms 
The Evolutionary Algorithm is a computational intelligence technique inspired by natural 
evolution and survival of plants and animals. The original basis of the technique is 
Darwin’s theory of natural selection. Biologically inspired computation is one of the 
fields inspired by Darwin’s theory which is considered to be one of the most prominent 
and important works in the history of human civilization (Serrano &  Castillo, 2012) . The 
notion suggests that all living things on earth today are results of millenniums of 
adaptations to natural environment. It is based on observation that in an ecosystem, 
different organisms must share resources. The most skilled organism in securing the 
resources and reproduction are most likely to have surviving offspring. Whilst organisms 
that are less skilled may have none or only few descendants left in the future. This was 
summarised clearly in a chart by Gregory (2009) - see Figure 3.3. The concept is known 
as ‘the fittest survive’ or ‘the survival of the fittest’ (Eiben & Smith, 2003). EAs mimic 
this part of nature to optimize a solution to a predefined problem. 
3.2.1 EAs basic elements and components 
Since the 1960s, many algorithms with similar properties have been proposed that 
resulted in several different types and versions of EAs. The major ones are genetic 
algorithms, evolutionary programming and genetic programming. However, almost all 
EAs share a number of common elements (Coello et al., 2007; Yu & Gen, 2010) : 
 
a) Population-based. EAs maintain a group of solutions, called a population (of 
individuals), to optimize or learn the problem for potential solutions, instead of a 
single candidate solution at a time. 
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b) Fitness-oriented. EAs used a selection method biased by fitness. Every individual 
has its performance evaluation, called its fitness value. The better the fitness of an 
individual, the more often it is selected and the more some parts of its "genetic 
material” (parts of its candidate solution) will be passed on to later generations of 
individuals. 
 
c) Variation-driven. New individuals based on the selection of older ones are 
generated by randomised processes intended to model mutation and 





Basically, EAs try to find solutions by going through repetitive steps of selecting the best 
candidate based on its fitness. Initially, given a problem to solve, a set of candidate 
                                 Figure 3.3: The Basis of Natural Selection by Darwin. 
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solutions is randomly generated. The set is known as a population and the candidate as 
an individual to that population. Every individual in the population is assigned, by means 
of a fitness function, a measure of its goodness with respect to the problem under 
consideration. Based on this fitness, some of the better candidates are chosen to seed the 
next generation by applying crossover and/or mutation to them. In essence, crossover 
swaps some genetic material between two or more individuals, while mutation changes 
the value of a small part of the genetic material of an individual to a new random value, 
simulating self-replication of individuals. Executing crossover and mutation leads to a set 
of new candidates (the offspring) that compete - based on their fitness (and possibly age) 
- with the old ones for a place in the next generation. This process can be iterated until a 
candidate with sufficient quality (a solution) is found or a previously determined 
computational limit is reached. In the form of pseudo code, the process can be written as 
in Figure 3.4 (figure from Eiben & Smith (2003)). The key components and steps are 










3.2.2  Applications of evolutionary algorithms 
Many activities involve unstructured, real life problems are difficult to model, since they 
require several unusual factors. Certain engineering problems are complex in nature: job 
shop scheduling problems, timetabling, traveling salesman or facility layout problems. 
For all these applications, evolutionary computation provides a near-optimal solution at 
the end of an optimisation run. Evolutionary algorithms are thus made efficient because 
they are flexible, and relatively easy to hybridize with domain-dependent heuristics. 
Applications of evolutionary computation include the following fields: 
• Medicine and healthcare 
• Engineering application (including electrical, mechanical, civil, production, 
aeronautical and robotics). 
• Traveling salesman problem. 
• Machine intelligence. 
                                          Figure 3.5: Important elements of EA 
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• Expert system 
• Network design and routing 
• Wired and wireless communication networks. 
(Sivanandam & Deepa, 2008) 
 
 
Evolutionary algorithms in Medicine and Healthcare 
Since EAs were developed decades ago, they have been used to solve problem in 
medicine. EAs are considered as an alternative approach to medical quantitative studies 
(that employ statistical methods) ( Smith, 2011). Examples of EA applications in medical 
and healthcare include: 
• Medical imaging: image segmentation, image registration, reconstruction and 
correction, detection of breast cancer. 
• Data mining medical data and patient records 
• Clinical expert systems and knowledge-based systems: computer aided detector 
for breast cancer, decision support system for the diagnosis and classification of 
heart disease. 
• Modelling and simulation of medical processes 
• Clinical Diagnosis and Therapy: automated heart disease diagnosis, diagnosis of 
Parkinson’s disease, diagnosis of language impairments in speech pathology, 
diagnosis of Alzheimer’s disease, drug design, medicinal chemistry and predictive 
toxicology. 





3.3 Genetic Programming 
Genetic Programming (GP) is a well-known branch of EAs. It became more widely 
adopted after the publication of John Koza’s book in 1992 (Koza, 1998). The most 
important feature of GP is its ability to automatically generate functional programs from 
a high-level statement of the problem. This addresses one of main challenges of computer 
science that is to get a computer to do what needs to be done, without telling it how to do 
it. This idea can be expanded to generate artificial intelligence by computer (Yu & Gen, 
2010). 
GP may be defined generally as any direct evolution or breeding of computer programs 
for the purpose of inductive learning. In particular, this definition leaves GP independent 
of a special type of program representation (Brameier & Banzhaf, 2007). GP is closely 
related to genetic algorithms (GA) and based on the same Darwin’s principal of “survival 
of the fittest”. Only in the case of GP, the initial population consists of computer programs 
which are generated randomly. However, three important differences exist between GAs 
and GP (Sivanandam & Deepa, 2008) : 
 
Structure: GP usually evolves tree structures while GAs evolve binary or real number 
strings. 
 
Active vs Passive: Because GP usually evolves computer programs, the solutions can be 
executed without post processing i.e. active structures, while GA’s typically operate on 
coded binary strings. i.e. passive structures, which require post-processing. 
 
Variable vs fixed length: In traditional GAs, the length of the binary string is fixed before 
the solution procedure begins. However, a GP parse tree can vary in length throughout 
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the run. Although it is recognised that in more advanced GA work, variable length strings 
are used. 
3.3.1 General form of GP 
 The representation used by genetic programming is in the form of executable 
computer programs. There are many different forms of computer programs which are 
used in genetic programming implementations, but most of them use a tree-structured 
representation. (Other representations commonly used will be introduced later in this 
section.) Usually there are two types of nodes in representing individuals: Terminals and 
Functions. 
 
Terminals are inputs to the program; they can be constants or variables. Figure 3.6 shows 
an example of a tree-structured representation for a genetic programming implementation. 
In the example a, b, y and integers are terminals. 
 
Functions take inputs and produce outputs and have some possible side-effects. The 
inputs can be terminals or the output of other functions. In the above example +, /, *,- and 
sin are functions. The functions may be standard arithmetic operations, standard 
mathematical functions, logical functions, standard programming functions or domain 
specific functions. 
 
Genetic Operators of reproduction, crossover and mutation are three basic operators in 





Reproduction: The reproduction operation for genetic programming is asexual operation 
where it operates on only one parent and produces only one offspring. The operation of 
reproduction consists of two steps. First, a single parent is selected from the population 
according to some selection method based on fitness. Second, the selected individual is 
copied, without alteration, from the current population into the new population 
 
Crossover:  The crossover operation generates a new offspring that consists of parts of 
its parents. In Figure 3.7(a) there are two parent: A and B. Each parent independently 
selects a point for crossover operation randomly. Then two offspring will be generated by 
swapping two selected fragments of parents to produce children Figure 3.7 (b). 
 
Mutation: In genetic programming a point is selected at random within a selected 
individual. The mutation operation then removes whatever is currently at the selected 
point and whatever is below the selected point and inserts a randomly generated sub-tree. 
Another method is to randomly find a function node anywhere on the tree and then replace 
the function with another selected at random, from the set of functions, where the function 
takes the same number of arguments. 
 




In general, the process of GP can be executed by the following three steps (Koza, 1998) 
(1) Generate an initial population of random compositions of the functions and 
terminals of the problem (computer programs). 
(2) Iteratively perform the following sub steps until the termination criterion has been 
satisfied: 
a) Execute each program in the population and assign it a fitness value according 
to how well it solves the problem. 
b) Create a new population of computer programs by applying the following two 
primary operations. The operations are applied to computer program(s) in the 
population chosen with a probability based on fitness. 
(i) Copy existing computer programs to the new population. 
(ii) Create new computer programs by genetically recombining randomly 
chosen parts of two existing programs. 
                                                         Figure 3.7: Crossover operation. 
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(3) The best computer program that appeared in any generation (i.e., the best-so-far 
individual) is designated as the result of genetic programming. This result may be 
a solution (or an approximate solution) to the problem. The whole cycle visualised 





3.3.2 Other representation of Genetic Programming 
GP is traditionally represented by a tree structure as explained earlier. However, non-tree 
representations have been suggested and successfully implemented. The other two 
popular representations of GP are linear and graph representations (Banzhaf et al., 1998). 
 
Linear Genetic Programming (LGP) 
LGP is where computer programs in a population are represented as a sequence of 
instructions from machine language. In linear GP programs are linear sequences of 
                                      Figure 3.8: Genetic Programming cycle. 
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instructions, as shown in Figure 3.9. The number of instructions can be fixed or varies. It 
means that all the programs can have the same length or that different individuals can 




As in machine language instruction execution, in linear GP, instructions read their 
input(s) from one or more registers or memory locations and store the results of their 
calculations in a register. Instructions in linear GP all have equivalent roles and 
communicate only via registers or memory. In linear GP there is no equivalent of the 
distinction between functions and terminals which is fundamental in tree-based GP. Also, 
in the absence of loops or branches, the position of the instructions determines the order 
of their execution. 
Originally there are two types of linear GPs: machine code GP, where each 
instruction is directly executable by the CPU, and interpreted linear GP, where each 
instruction is executable by some higher-level virtual machine (typically written in an 
efficient language such as C or C++). When the instructions are actual machine code, then 
the order of the elements of the representation shown in Figure 3.8 is determined by the 
particular computer architecture used, and the corresponding data must be packed into bit 
fields of appropriate sizes. On the contrary, when one is using virtual machine instructions 
the designer of a GP system has complete freedom as to how the virtual machine will 
interpret its instructions. If the goal is execution speed, then the evolved code should be 
machine code for a real computer rather than some higher-level language or virtual 
machine code (Poli et al., 2008). 
                                                         Figure 3.9: Typical LGP representation. 
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Graph-based Genetic Programming 
Starting from the middle 1990s, researchers have proposed several extensions of GP that 
able to evolve graph-like programs. A few examples of variants for this branch of GP are 
Parallel Distributed GP (PDGP), Parallel Algorithm Discovery and Orchestration 
(PADO), and Cartesian GP. Riccardo Poli in Poli (1996) proposed an approach called 
parallel distributed genetic programming (PDGP). Poli stated that PDGP can be 
considered as a generalization of GP. However, PDGP has more complex representations 
and evolves finite state automata, neural networks and more. In PDGP programs are 
represented in as graphs with nodes representing functions and terminals. 
In a system called parallel algorithm discovery and orchestration (PADO), a 
combination of GP and linear discrimination was used to obtain parallel classification 
programs for signals and images. The actions are drawn from a primitive set including 
the standard algebraic operations, minimum, maximum, negation, read from indexed 
memory; write to indexed memory, deterministic and non-deterministic branching 
instructions, and primitives related to the task of classifying images (Poli et al., 2008). 
The traditional tree representation of programs is the root of GP, even though many 
different GP approaches and program representations exist. A general motivation for 
investigating different representations in evolutionary computation is that for each 
representation form, as is the case for different learning methods in general, certain 
problem domains may exist that are more suitable than others (Brameier & Banzhaf, 
2007). 
3.3.3 Classification applications of GPs 
Daily, huge amounts of data are being stored in databases around the world. This creates 
both an opportunity and a need to discover the knowledge in such databases. If such 
knowledge discovery activity is successful, discovered knowledge can be used to improve 
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the decision-making process of an organisation (Freitas, 2010). Research fields such as 
statistic and machine learning have been used to gain the knowledge from real- world 
data sets. It is also known as data mining. Classification is probably the most studied data 
mining task and EA is an evolutionary learning technique that offers a great potential for 
classification (Espejo et al., 2010). Classification can serve many different purposes, like 
credit scoring, bankruptcy prediction, medical diagnosis, and so many more. 
The advantages of application of GP to classification task include: 
• Flexibility, which allows the technique to be adapted to the needs of each problem. 
• GP can be employed to construct classifiers using different kinds of 
representations. 
• GP can be useful not only for inducing classifiers, but also for other pre- 
processing and post processing tasks aimed at the enhancement of classifiers. 
• Interpretability, GP can employ more interpretable representation formalisms, like 
rules and automatic feature selection. 
In the classification task each data instance (or database record) belongs to a class, which 
is indicated by the value of a goal attribute. This attribute can take on a small number of 
discrete values, each of them corresponding to a class. Each instance consists of two parts, 
namely a set of predictor attribute values and a goal attribute value. The former are used 
to predict the value of the latter. The predictor attributes should be relevant for predicting 
the class (goal attribute value) of a data instance. For example, if the goal attribute 
indicates whether a patient has or will develop a certain disease, the predictor attributes 
should contain medical information relevant for this prediction. 
In a simplified version of the classification task, first the set of data instances is 
randomly divided into two subsets, called the training set and the test set. The training set 
is made entirely available to the search algorithm, so that the algorithm has access to the 
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values of both predictor attributes and the goal attribute for each data instance. The aim 
of the algorithm is to discover a relationship between the predictor attributes and the goal 
attribute using the training set. In order to discover this relationship, the algorithm has 
access to the values of both predictor attributes and the goal attribute for all instances of 
the training set. The discovered relationship is then used to predict the class (goal-attribute 
value) of all the data instances in the test set.Apart from construction of a classifier from 
a dataset, there are some other related tasks that usually have to be addressed as well such 
as data pre-processing and model interpretation and enhancement (Espejo et al., 2010). 
 
Data pre-processing. Model extraction techniques are not usually applied to the database 
in its original form. There are a great variety of pre-processing techniques available in 
order to prepare the data to take advantage of its maximum potential. Some of the issues 
to consider are s u ch  a s  the removal of noise or outliers, strategies for handling 
missing data, feature selection and construction, instance selection, data rebalancing and 
data projection, and normalisation. 
 
Model interpretation and enhancement. Sometimes the classifier obtained is not 
readily usable, and some kind of post-processing is necessary. Some of the issues to be 
addressed at this point may include the elimination of redundant knowledge, application 
of visualisation techniques, evaluation of the model obtained, translation to a more 






3.4 Cartesian Genetic Programming 
Cartesian genetic programming (CGP), introduced by Miller and Thomson (Miller & 
Thomson, 2000), is a form of genetic programming where the candidate solutions are 
represented as a string of integers of fixed length that is mapped to a directed oriented 
graph. CGP can efficiently represent common computational structures including 
mathematical equations, computer programs, neural networks and digital circuits. CGP is 
Cartesian in the sense that the method considers a grid of nodes that are addressed in a 
Cartesian coordinate system. Although CGP is relatively new to other GPs, it has shown 
great potential with a wide range of applications. 
 
“Cartesian Genetic Programming (CGP) is now attracting considerable 
recognition as an evolutionary algorithm that not only delivers high 
performance, but one that has a representation that is flexible and easy to adapt 
to a range of applications. “ 
(Smith, 2011) 
 
3.4.1 General form of CGP 
The graphs in CGP are represented as a two-dimensional grid of computational nodes. 
The genes that make up the genotype in CGP are integers that represent where a node 
gets its data, what operations the node performs on the data and where the output data 
required by the user is to be obtained. When the genotype is decoded, some nodes may 
be ignored. This happens when node outputs are not used in the calculation of output data. 
When this happens, the nodes and their genes are referred as ‘non-coding’. Programs that 
result from the decoding of a genotype is called phenotype. The genotype in CGP has a 
fixed length. However, the size of the phenotype (in terms of the number of computational 
nodes) can be anything from zero nodes to the number of nodes defined in the genotype. 
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A phenotype would have zero nodes if all the program outputs were directly connected 
to program inputs. A phenotype would have the same number of nodes as defined in the 
genotype when every node in the graph was required. The genotype–phenotype mapping 
used in CGP is one of its defining characteristics.  
The types of computational node functions used in CGP are decided by the user 
and are listed in a function look-up table. The function gene is the address of the 
computational node function in the function look-up table. The connection genes 
determine where the node gets its data from. These genes represent addresses in a data 
structure (typically an array). Nodes take their inputs in a feed-forward manner from 
either the output of nodes in a previous column or from a program input (also known as 
a terminal). The number of connection genes a node has is chosen to be the maximum 
number of inputs (often called the arity) that any function in the function look-up table 
has. The program data inputs are given the absolute data addresses 0 to ni - 1 where ni is 
the number of program inputs. The data outputs of nodes in the genotype are given 
addresses sequentially, column by column, starting from ni to ni +Ln −1, where Ln is the 
user-determined upper bound of the number of nodes.The general form of a Cartesian 
genetic program is shown in Figure 3.10 (figure from Miller (2011)). If the problem 
requires no program outputs, then no integers are added to the end of the genotype. In 
general, there may be several output genes (Oi) which specify where the program outputs 
are taken from. Each of these is an address of a node where the program output data is 





CGP encodes a candidate solution (typically a circuit or a program) using an array 
consisting of c x r programmable nodes. The c determines the number of columns and r 
determines the number of rows. These are two out of three parameters that are chosen by 
the user. The third one is levels back, denoted by l. The product of the first two parameters 
determine the maximum number of computational nodes allowed: Ln = ncnr. The 
parameter l controls the connectivity of the graph encoded. Levels-back constrains which 
columns a node can get its inputs from. If l = 1, a node can get its inputs only from a node 
in the column on its immediate left or from a primary input. If l = 2, a node can have its 
inputs connected to the outputs of any nodes in the immediate left two columns of nodes 
or a primary input. Each node input can be connected either to the output of a node placed 
in the previous l columns or to one of the program inputs. Because of the complicated 
evaluation, feedback is not allowed in the standard version of CGP. The main feature of 
CGP is that all the parameters including the number of programmable nodes is fixed. It 
means that the array of programmable nodes can be encoded as a string of integers which 
has the fixed number of items. The main advantage of CGP encoding is that even if the 
                                                          Figure 3.10: General form of CGP. 
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size of chromosome is fixed, the size of phenotype is variable since some nodes need not 
to be used. 
An example of 2 x 2 nodes CGP network is shown in Figure 3.11 from  Smith, 
(2011). Inputs, I/P 0 and I/P 1 feed the input values to the network, manipulated by 
function in each node and deliver the result to the output, O/P 0. The reference number of 
each node is shown in the top right-hand corner of each node. Table 3.2 shown example 
of a look-up table that listed user defined functions of the nodes in the network. 
 
 














Table 3.2: Example of function set look-up table. 
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3.4.3 Evolution of CGP genotypes 
CGP uses two common EAs operators; mutation and crossover /recombination. The 




A point mutation operator is used in CGP. In a point mutation, an allele at a randomly 
chosen gene location is changed to another valid random value. If a function gene is 
chosen for mutation, then a valid value is the address of any function in the function set, 
whereas if an input gene is chosen for mutation, then a valid value is the address of the 
output of any previous node in the genotype or of any program input. Also, a valid value 
for a program output gene is the address of the output of any node in the genotype or the 
address of a program input. The number of genes in the genotype that can be mutated in 
a single application is determine by a user defined mutation rate, μr which is normally a 
percentage of the total number of genes in the genotype. An example of point mutation is 
shown in Figure 3.12 ( Figure from Miller (2011)). 
 
Crossover 
Recombination operators have received relatively little attention in CGP. Originally, a 
one-point crossover operator was used in CGP (similar to the n-point crossover in genetic 
algorithms) but other studies also suggest improvement to the performance of CGP by 
using floating-point crossover operator (Clegg et al.,2007). 
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                                                          Figure 3.12: Point Mutation process. 
 
3.4.4 Evolutionary strategy 
CGP usually uses a variant of a simple algorithm called (1 + 4). Figure 3.13 shown the 
procedure of 1 + 4 strategy (from (Miller, 2011)). One of the conditions of the algorithm 
is an offspring is always chosen as a new parent if it is equally as fit or has better fitness 
than the parent ( Figure 3.14). When offspring genotypes in the population have the same 
fitness as the parent and there is no offspring that is better than the parent, in that case an 
offspring is chosen as the new parent (Figure from Miller & Thomson ( 2000)). 
 
 




                                              Figure 3.14: Priority to offspring with same fitness as parent. 
 
3.4.5 CGP medical applications 
There are many examples where CGP and its variants have been used in classification 
tasks involving medical data. One of the early examples is a work that classifies 
mammogram data in detection of breast cancer (Hope et al., 2007). Also, on detection of 
breast cancer, a CGP variant, Cartesian genetic programming evolved artificial neural 
networks (CGPANN) have been used in Ahmad et al. (2012) to determine whether a 
breast cancer is ‘‘malignant’’ or ‘‘benign’’ based on features of breast mass. Other 
examples are classifications for diagnosis of Alzheimer’s disease (Hazell & Smith, 2008), 
classification of arrhythmia for Cardiovascular diseases (Ahmad et al., 2013) 
discriminating normal and cancerous thyroid cell lines (Lones et al., 2010), classifications 










Machine learning is not a new founded field, yet it continues to expand with algorithms 
inspired by new inspirations from biology and nature. Consequently, there are a great 
number of algorithms to choose from for problem solving. In a classification task, popular 
algorithms such as Support Vector Machines (SVMs) and Artificial Neural Networks 
(ANNs) usually perform very well. However, the ANN is a ‘black box’ that makes 
understanding of how the problem was solved, difficult to achieve. SVM also does not 
provide rationale for the resulting classification decisions. This study’s main objectives 
are to differentiate and characterise movement disorders. Although popular algorithms 
such as SVM and ANN can differentiate very well, they cannot help with characterisation 
to the same degree. An evolutionary algorithm such as Genetic Programming (GP) is 
more suitable for this task. In this thesis, the main algorithm used is Cartesian Genetic 
Programming (CGP). CGP is a type of graph-based genetic programming with increasing 
applications across many aspects of real life. CGP typically finds good solutions 
efficiently in few evaluations. Although it uses many generations, it also uses extremely 
small populations, of typically five individuals, where one individual is the fittest from 
the previous generation. Other advantages of CGP is that it does not bloat like other forms 
of GP and sub functions can be easily reused in the Cartesian representation. CGP has 
been shown to successfully classify and characterised medical data in previous examples, 















                                                            
Methodology 
This chapter describes the methodology adopted in obtaining measurements from patients 
in the respective clinical studies undertaken in medical centres as part of ongoing research 
in collaboration with University of York . 
Participants with different neurological disorders and healthy adults (controls) were 
recruited by qualified clinicians in two medical centres: 
• Leeds Teaching Hospitals NHS Trust, UK 
• Monash Medical Centre, Melbourne, Australia 
All patients have an established clinical diagnosis according to the relevant diagnostic 
criteria, established at the respective medical centres. Controls are healthy adults with  no 
expression or history of a medical disorder that could affect movement. 
4.1 Data Collection 
Data collections were administered in line with the protocols written for the study under 
investigation but share common clinical settings in comparable testing environments for 
clinical evaluation. All subjects provided informed written consent and approval was 
 
obtained from Yorkshire and Humber Sheffield Research Ethics Committee (HREC code: 
14/YH/0143). 
4.1.1 Equipment 
The Polhemus Patriot EM tracking sensor system, a motion tracking system is used for 
data collection. The Polhemus device comprises a system electronics unit (SEU), a 
magnetic transmitter and two electromagnetic (EM) tracking sensors (Figure 4.1). The 
transmitter serves as the system’s reference frame where the EM sensors record positions 
and orientations relative to the transmitter in six degrees of freedom with an update rate 




The collection of data was administered in a clinical setting as a common practice of 
motor examination of MDS-UPDRS. The electromagnetic sensors (EM sensors) were 
attached to the thumb and index finger using Velcro tapes (Figure 4.2). For consistency, 
the sensors were attached at the same places during the administration of all the three 
tasks. The Polhemus device is based on varying magnetic fields. Large metal objects can 
affect the fields, and this adversely affects the results. Therefore, care was taken to 
Figure 4.1: Polhemus Patriot system (www.polhemus.com), a motion tracking system used to record 
movements during the motor assessment. a) SEU, b) magnetic transmitter cube and, c) EM sensors. 
 
examine the effect of metal objects used in performing the tasks. The position of subjects 
and their distance from the Polhemus transmitter cube during measurement is also 
important. 
 
                              Figure 4.2: EM sensors were attached on nail beds of index finger and thumb. 
 
This is due to the manufacturer recommended maximum distance from the sensors to the 
transmitter is about 150 cm; beyond this limit, the recordings will be interrupted. To make 
sure the positions of sensors were always within the working distance, clinicians used a 
fixed arrangement for the subject and the equipment as shown in Figure 4.3. 
 
 
Figure 4.3: Arrangement of the motion tracking system and participant position during movement 
recordings. 
 
After the sensors were fastened to the thumb and index finger, the participant was 
requested to sit straight with their back to the chair. Next, they were asked to lift their 
dominant hand unsupported so that it was around the level of their shoulder. The clinician 
demonstrates the correct way to perform the task, but the demonstration was not carried 
on during the execution by the participants. The participants were not allowed any 
practice movement; the first attempt was recorded as the experimental data. The recording 
was only repeated if there were technical problems such as the system was not recording, 
or the output file was not saved automatically to the storage or the sensors were not at 
correct positions. After the measurement the dominant hand was repeated two times, the 
sensors then were attached to the non-dominant hand to complete the same measurement. 
The Patriot system allows for customisation of the interface (Figure 4.4) where the tasks 
were sequenced along with instructions on how to execute the task. Before the recording 
started, clinicians can enter demographic and medical information of the participant. 
When the recording of movements was completed, the system stores the data file 
at a designated location with a pre-determined file name that combined unique participant 
code along with date and time of the assessment. The created interface and automatic 
storage system ensured clinicians (involved in this study) in different centres to follow 
the same protocol of the assessment and data storage management. Encrypted data files 
were hand-delivered or transmitted electronically from the test centres to the University 







Figure 4.4: An example of the interface created to ensure the same protocol was followed by clinicians 
from different centres. 
 
4.1.2 Movement tasks 
The Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS) was used as the conventional clinical evaluation from which participant 
measurements were to be captured. The MDS-UPDRS has four sections: 
Part I: non-motor experiences of daily living  
Part II: motor experiences of daily living  
Part III: motor examination, and 
Part IV: motor complications 
Part I, II and IV are based on the history taking of the subjects by the clinician and 
patients personal notes (if any). Part III, also referred to as the motor section, is based on 
the examination by the clinician. This rating scale evaluates the severity of PD symptoms 
in a 5-points scoring system (0 for no symptom and 4 for a marked severity of the 
symptom). 
 
For this study, subjects performed the following MDS-UPDRS items 
• Finger tapping 
• Hand opening-closing (written as hand movements in MDS-UPDRS) 
• Pronation/Supination 
4.2 Computation of movement features 
Based on the literature and direct consultations with clinicians involved in the research, 
movement features were extracted from the recordings and used as input to the classifiers. 
The nature of the movement in each task also considered. The features extracted contain 
important information about the bradykinesia characteristics of every movement task. In 
order to calculate the features, the data were first pre-processed. 
4.2.1 Data pre-processing 
The Polhemus device returns the recordings of movements for both sensors in a text file 
consisting of eight columns (Figure 4.5). The first column is sensor numbers: 01 refers to 
thumb sensor and 02 is finger sensor. The next three columns give readings for the 
Cartesian coordinates of X, Y and Z, in that order. Columns four to six are for orientations 
 
in Euler angles: azimuth, elevation and roll respectively. The last column is the time stamp 





In a study of movement where the signal is anatomical coordinate that changes with time, 
noise might be a problem. The presence of this higher-frequency noise is of considerable 
importance when considering the problem of trying to calculate velocities and 
accelerations (Winter, 2009). The kinematics data in this research were pre-processed to 
remove noise using the Low Pass 5Hz Butterworth filter. The Butterworth filter is the 
most common filter used in biomechanics data analysis due to its excellent passband 
response (Christodoulakis et al., 2010). Figure 4.6 shows an example of raw finger 
tapping data plot against time before and after passing through the filter. 
Figure 4.5 : Content of the text file returns by Polhemus device contains recordings of the movement in six 
degrees of freedom. 
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Figure 4.6: The raw data of Cartesian coordinates in the left column effectively smoothed using Butterworth 
filter as shown in the right column. 
 
4.2.2 Finger Tapping computed features 
As mentioned in Chapter 2, finger tapping task is a very popular task in studies that 
evaluate motor symptoms of PD. Previous studies using finger tapping to assess 
movement disorders were detailed in Section 2.4. In this study, nineteen kinematic 
features were selected to represents FT movement. The selection of the features was based 
on the literature and direct consultation from the clinicians involved in this study. Most 
of the features were adapted directly from Lacy (2013). Lacy  used the same  FT protocol 
and equipment with this study and successfully evolved very high-performance classifiers 
of PD and healthy controls. The rest of the features were based on findings from Yokoe 
et al. (2009), Stamatakis et al. (2013), Jobbágyly et al. (2005), Espay et al. (2009) and  





                                       Table 4.1: Movement features of finger tapping task. 
Feature Previous study 
Mean amplitude  
Mean speed 
Max opening acceleration 
Max opening deceleration 
Max closing acceleration 
Max closing deceleration 
Periodicity  
COV amplitude ( amplitude rhythm) 





Decrementing speed  
Cycles frequency  
Stamatakis et al. (2013) 
Amp*freq Jobbágyly et al. (2005) 
Max overall amplitude 
Max overall speed 
Espay et al., (2009) 
Max opening speed 
Max closing speed 
Yokoe et al. (2009) 
 
The version of finger tapping in this study was administered as suggested in the motor 
section of MDS-UPDRS. Participants were guided to continually tap their index finger to 
the thumb as fast and as widely as possible for ten repetitions. There are two phases of 
finger tapping task, closing phase and opening phase ( Figure 4.7). The sequence started 
with the closing phase. For the finger tapping task, only positional data of x, y and z are 
used for the calculation of the features. The separation distance between the finger and 
the thumb during the finger tapping action was computed by first calculating the difference 
between the x, y and z coordinate values for the respective sensors (Xd, Yd and Zd), and 
then, calculating the Euclidean distance, or overall positional separation, between index 








The Euclidean distance D, was calculated as: 
 
However, different hand sizes of subjects can give the effect of bigger or smaller 
amplitude that may result in vary speeds and accelerations of tapping sequences 
dependent on hand size. Additionally, as the sensors were placed on the nails beds, there 
was a gap between two sensors that depended on the thickness of the subject’s thumb and 
finger. The gap was considered as the minimum separation during measurement. To avoid 
this human factor affecting the calculation results, the separation data were normalised to 
scale of 0 to 1 to represent the relative distance between the thumb and finger. To do this, 
first, the minimum separation value for each subject was subtracted from all its other 
separation data points. The resulting values were then divided by the maximum separation 
of the tapping recording. The normalised separation time series data, Dn, then was 
differentiated to produce the speed time series data (dDn/t) and then differentiated again 
to give the acceleration time series data (dDn2/t). Figure 4.8 shows examples of 




Figure 4.8 : Visuals of time series kinematic FT data. From top is amplitude in centimetres, velocity and 
acceleration for ten cycles of finger tapping. 
 
 
Calculation of movement features 
There are two approaches for calculating the features; most of the features are based on 
individual finger tapping cycles, but some features were calculated over the whole taping 
sequence. 
 
A. Calculation within a single finger tap cycle 
A full FT cycle comprises completed closing and opening phases. The closing phase 
begins once the sensors move towards one another after the point of maximal separation 
and finishes when the sensors have achieved a minimum separation; the opening phase 
begins once the fingers are separated, from an initially closed position equating to a 
minimal distance between the sensors to when they are maximally separated (Figure 4.9). 
Minimum, maximum and average of the normalised amplitude, speed and acceleration of 
both cycle phases were computed. 
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The features were calculated as follows:  
Amplitude 
The term amplitude here refers to the normalised separation values between sensors 
during the FT movement, thus, generating values between 0 and 1. 
• Maximum overall amplitude: The maximum amplitude for each FT cycle was 
taken, the mean over the whole test then calculated to obtain a single value for 
each test. 





Figure 4.9: Separation data are showing opening and closing phases of a tapping cycle. Maximum amplitude 




The speed instead of velocity is calculated because the goal is to observe the slowness 
regardless of the direction of movement. The following speed components were 
calculated: 
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• Maximum overall speed: The maximum speed reached in every FT cycle is 
averaged to obtain this value. 
• Maximum opening speed: The average maximum speed of individual FT cycles 
during the opening phase 
• Maximum closing speed: The average maximum speed of individual FT cycles 
during the closing phase 
 
Acceleration and deceleration 
Acceleration and deceleration in cm/s2 were calculated separately for opening and closing 
phases of each FT tap. The following components were calculated: 
 
• Maximum opening acceleration: The fastest acceleration during the opening 
phase of each FT tap was taken. The values were then averaged to get a single 
value for each test. 
• Maximum opening deceleration: The most negative acceleration during the 
opening phase of each FT tap was taken. The values were then averaged to get a 
single value for each test. 
• Maximum closing acceleration: The fastest acceleration during the closing 
phase of each FT tap was taken. The values were then averaged to get a single 
value for each test. 
• Maximum closing deceleration: The most negative acceleration during the 
closing phase of each FT tap was taken. The values were then averaged to get a 




Measures of amplitude and speed alone may not be sufficient to capture the full movement 
patterns of subjects. For example, a subject may be faster due to smaller amplitude and 
vice versa. To express the relationship between these components a variable called 
periodicity was calculated for each tap cycle as follows: 
 
 








Patients often have difficulties in performing the exact number of the cycles as instructed. 





Decrementing amplitude and speed 
To calculate the decrementing trend, maximum separation amplitude or speed for each 
tap cycle, each value was linearly regressed against the number of cycles. A negative 
slope indicates that the overall trend of a movement component measure is decrementing 
and a zero or positive slope indicates that there is no decrementing pattern. Figure 4.10 
provides examples of linear regression plots of maximum amplitude to obtain the slope 







Halts were measured by calculating the percentage of the tap cycle duration spent at ‘zero’ 
speed. ‘Zero’ speed is assumed as when the speed is less than five percent (< 5%) of the 




When the movement showed smaller peaks between tapping cycle phases (Figure 4.11), 
it is treated as hesitation. All the hesitations detected in a test total up to a single value. 
                                  Figure 4.10: Amplitude decrement pattern 
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                                                               Figure 4.11: Hesitations in tapping cycle 
 
 
Coefficient of Variation (COV) 
To measure rhythm, the Coefficient of Variation (COV) was used. COV reflects how 
much a movement component measure varies over a defined period. It shows how 
rhythmic the repetitive movements are. High COV values imply less rhythmic 
movements than small COV values. COV of amplitude and speed were calculated over a 




Bigger amplitude with greater frequency during finger tapping means faster finger 
movement. This is considered to be a better performance. Alternatively, the movement 
can be executed faster with smaller amplitude. The amplitude × frequency of tapping is 
suggested in  Jobbágy et al. (2005) to characterise the speed. This feature is determined for 
each tapping cycle and then averaged over the whole test. 
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All nineteen features extracted from the finger tapping (FT) task were given input 
numbers to be used as classifier inputs  (Table 4.2). 
 
                               Table 4.2: FT extracted features with classifiers input numbers 
 
 
4.2.3 Hand pronation-supination computed features 
For the hand pronation-supination task (PS), the MDS-UPDRS requires the participant to 
extend the arm out in front of their body with the palms face down and then turn the palm 




Figure 4.12: Hand pronation-supination task: the phase when the palm is facing down is called pronation. 
Supination is the phase when subject twists the palm up from pronation phase. 
 
After some experimentation, it was concluded that the most useful data in our pronation- 
supination recordings came from the movement of the thumb. The PS cycle starts with 
the pronation phase followed by supination (Figure 4.13). Referring to  the thumb sensor 
recorded movement, when the position of thumb sensor (position A) begin to change at 
the beginning of the task, it is considered as the start of the pronation phase. When the 
sensor reaches point B and starts moving towards C, the supination phase starts. 
For analysis of movement using only one sensor, the amplitude is defined as the Euclidean 
distance between thumb sensor and Patriot transmitter. 
 
 
Speed was calculated by differentiation of each Cartesian coordinate component (x, y, z) 
over the sampling time to compute the respective velocity components (𝑣𝑥,𝑣𝑦,𝑣𝑧 ) . The 








                                              Figure 4.13: Phases of pronation-supination. 
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Acceleration is obtained by differentiating the speed, using the same sampling time. The 
same method of calculation as in Section 4.2.2 was used to compute items (0) to (18) in 
Table 4.3. 
4.2.4 Hand opening-closing 
Item 3.5 in MDS-UPDRS is hand movements, which is known as hand opening-closing 
in this study. In this task, participants were first instructed to make a tight fist with the 
arm bent at the elbow so that the palm faces the examiner (Figure 4.14). Subjects were 
then asked to open the hand as fully and as quickly as possible. The participant repeated 
the opening and closing movements ten times. 
 
 
Figure 4.14: The phases of hand opening-closing task. Subject starts with the hand closed by making a fist 
and proceeds to the opening phase by fully opens the hand.. 
 
 
In the hand opening-closing task, sensors were placed at the same positions as in the 
finger tapping task. However, unlike finger tapping, which is a simultaneous movement 
of thumb and fingers, the hand-opening task involves two steps movement. Therefore, the 
selection of extracted features was considering the measurements of both sensors 
separately. The cycle of the HO task started from the closing position to maximum 
amplitude opening and back to closing position. Figure 4.15 shows the task cycle 
represented by the movement of the finger sensor (FS) amplitude. 
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The calculation of amplitude for each sensor used the Euclidean distance between the 
Patriot transmitter and the sensor itself (as in section 4.2.3). The speed and acceleration 
is then calculated from the amplitude values. . The maximum values for each sensor are 
the highest from both phases, opening or closing. For example, to get FS maximum 
speed, the maximum speeds of the finger sensor during the opening and closing phases 




                                     Figure 4.15: The opening and closing phases of the HO task. 
 
 
The thumb and finger movement data executing the HO task were used to compute the 














                                         Table 4.4: Hand-opening extracted features. 
 
 
4.3 CGP Classification 
The classification used a typical CGP evolutionary strategy which selects one parent from 
each generation and uses mutation to produce four children. The next generation then 
comprises the parent and the four children, giving a population of size five - four children 
plus one parent: (1+4) - ES. The fitness assigned to each classifier is simply the proportion 
of samples correctly classified. Previous CGP classifiers of FT (refer section 2.5) used 
the area under a ROC Curve (Fawcett 2006) as fitness function, but in this study, 
classification accuracy is used for simplicity and directcomparison.  
The CGP platform used to evolve the classifiers was developed by Turner & 
Miller, (2014) called the CGP-Library. The CGP-Library provides a number of structures 
including which describe the CGP parameters and CGP chromosomes.These structures 
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are initialised and freed up using provided functions. The following three CGP-Library 
structures are used to train and test classifiers. 
• The parameters structure is used to store general CGP parameters including the 
size of the chromosomes, the evolutionary strategy to use and the mutation rate. 
• The dataSet structure is used to store input output pairs of data which may be used 
by the fitness function.   
• The chromosome structure is used to store the fittest chromosome found after CGP 
has been applied towards the classification  task. 
Through experimentation, the CGP parameters values as in Table 4.5 were adopted. The 
function set comprised ({+, -,×,÷,mean, min, max, mode }).  
 
 
                            Table 4.5: CGP parameters adopted to evolve classifiers. 
Evolutionary strategies (1+4) - ES. 
Nodes available 15,50 
Node arity 2,5 
Mutation rate 0.05 
Function set ({+, −, ×, ÷, 𝑚𝑒𝑎𝑛, 𝑚𝑖𝑛, max, 𝑚𝑜𝑑𝑒}) 
Generations 10000 
 
The features extracted from the movement tasks were used as the inputs to evolve 
classifiers. For each movement recording, a set of input values were computed. The input 
values are floating numbers from calculation explained in Section 4.2. Each set of input 
was mapped to one output according to the group of the input data. For example, an input 
set belong to the Control group was given output ‘0’, and ‘1’ for PD group. Figure 4.16 
shown an example of CGP network with FT features as inputs. The number in bracket  
represents a node number; where a node can be an input node or a function node.  Each 
function node is labelled with a textural description of the operation it undertakes such as 
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‘add’. The nodes in the network are numbered sequentially starting at zero with the first 
of the input nodes. Therefore, the input numbers in the CGP network are tally with the 
input numbers in Table 4.2, 4.3 and 4.4. The movement features data  was fed into the 
algorithms in the form of dataset files. There were two text files in each 
 
Figure 4.16: Example of a CGP netwrork using FT movement features as input. 
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training-test cycle; the training file contained data to train a classifier and the test data that 
is later used to test the predictive accuracy of the evolved classifier. The CGP platform 
requires a specific format of dataset file. The header of the text file contains information 
on the number of inputs, outputs and lines of data samples (Figure 4.17). The following 
lines comprise the inputs followed by the outputs for each sample with all the values 
comma separated. In every sample line, the input values were arranged according to the 




           Figure 4.17: The computed features arranged in a text file to be used in the classification task. 
 
4.3.1 Repeated stratified K-fold cross-validation 
To compensate for any effect on results caused by small amounts of training and test data, 
the repeated k-fold cross-validation was used along with the stratification of data. 
In the k-fold cross-validation method, the overall data set is divided into separate k groups 
of the same, or approximately the same size. In each iteration, only a fold is used for 
evaluation (test set), and the rest of the folds are used for model training (training set). In 
machine learning, k= 10 is a very popular choice for the number of folds. However, in 
this study, the number of participants is not big enough to be divided into ten groups. 
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Thus, k =5 is used, and in some cases, k = 3. Figure 4.18 illustrates the 5-fold cross 
validation with A as the resulting accuracy which is the average of all iterations. 
 
                                       Figure 4.18:5-fold cross-validation technique. 
 
In small sample size classification such as in this study, a class imbalance can easily 
occur. This can happen in the partition itself, although the overall classes are balanced. 
For example, consider the healthy controls and PD patients’ dataset. There are kinematics 
data for 22 controls and 20 PD patients which is almost a balanced class distribution. 
However, when the data set is randomly partitioned, it is possible that the class 
balancewill be destroyed. The training set may contain more healthy controls than PD 
patients and the opposite for the test set. To avoid this, the data were stratified. It means 
that when the data were divided into groups (folds), the program was written to randomly 
pick a balanced number of subjects from both groups for each fold. The k-fold cross-
validation was repeated ten times for improving statistical significance and to increase 




4.3.2 Record-wise and Subject-wise cross-validation. 
Participants repeat the movement task twice for each hand. Each participant will have at 
least four different kinematic records of the same task. There are two ways the data can 
be partitioned for cross-validation: record-wise or subject-wise. In record-wise validation, 
all the records were used as different samples and randomly divided into training and test 
sets. Whilst in a subject-wise validation, the records for the same subject will not be in 
the training and test set at the same time. Figure 4.19 visualises subject-wise and record- 
wise cross-validation for clinical predictions. 
 
Figure 4.19: Visualisation of subject-wise and record-wise cross-validation used at the stage of selecting 
kinematic features into training and test set. 
 
Saeb et al. (2017) in their critical article proposed that in the clinical diagnostic 
application of machine learning, subject-wise CV should be used instead of records-wise 
CV. Using empirical evidence and simulation of classification on a few public database, 
they claimed that record-wise CV greatly overvalues the prediction accuracy of the 
algorithms used. They believed this is because records-wise CV creates a dependence 
between training and test sets due to shared subjects across train/test sets, so it will 
produce biased estimates. However, reviewers believed that it is not fair to oversimplify 
the application of the cross-validation technique and make assumptions based on the 
results of a few simulations (Little et al., 2017). In this study, both types of CV were used, 
and comparisons were made between the accuracies of both methods. 
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4.3.3 Comparisons with other methods of machine learning 
In medical classification, there are other methods that are popular and useful for the 
purpose of classifying classes (refer to Chapter 2). In this study, two other machine 
algorithms were used as a comparison to evaluate the performance of CGP in the 
classification task. The algorithms are Support Vector Machine (SVM) and Artificial 
Neural Network (ANN). 
For SVM, the WEKA default algorithm that employed sequential minimal 
optimization algorithm (SMO) for training a support vector classifier was used. The 
default settings used polinomial kernel function.  Different experiments were done using 
other kernel functions (Gaussian, linear) without any marked improvement in the 
accuracies, so the WEKA SMO default settings were used.  
The Neural network used was a feed-forward back propagation network with 20 
hidden layers and a tan-Sigmoid transfer function. The number of hidden layers was 
chosen using an iterative method; the number of hidden layers were increased gradually 
registering the maximum improvement in the results when 20 is considered. A greater 
number of hidden layers did not improve the results so the hidden layer number was 
chosen equal to 20. For both algorithms, 10-fold cross-validation was used , and all 
records treated as different instances (record-wise cross- validation)  
4.4 Summary 
There are many ways movement data collection can be done. We opted for the low-cost, 
easy to used equipment for this study. The motion tracker, Polhemus only used two 
electromagnetic sensors but able to records movement in six degrees of freedom. Good 
quality of data is very important in machine learning classification task. The data 
collected were pre-processed and explored to get to know the data. Based on previous 
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quantitative studies of PD motor tasks, many movement features were extracted. 
Statistical tests conducted for selection of useful features. The extracted feature were used 










                                                                 
Evaluation of Bradykinesia in Parkinson’s Disease and 
other movement disorders 
As discussed in Chapter 2, of the four main signs of Parkinson’s disease, bradykinesia is 
the only mandatory motor sign for a clinical diagnosis of PD ( Heldman et al., 2011). The 
complex nature of bradykinesia makes it difficult for clinicians to be certain of its 
existence in the early stages of Parkinson’s disease. Bradykinesia also exists in 
Huntington’s disease (HD), a genetically inherited neurodegenerative condition that 
causes movement disorders such as chorea (Garcia Ruiz et al., 2000; Martínez Pueyo et 
al., 2016; Thompson et al., 1988). On the contrary, there is research suggesting that 
bradykinesia is not a core feature of movement disturbance in HD (Duval et al., n.d.; 
Fenney et al., 2008). The same pattern occurs in the case of Essential Tremor. A few 
papers suggest Bradykinesia exists in ET (Duval et al., 2006; Goubault et al., 2017), but 
others oppose the idea (Özekmekçi, 2005). The aim of this work is to provide a better 
understanding of the characteristics of bradykinesia, how they differ between these 
conditions and may be used to confirm an early diagnosis and inform clinical assessment. 
In light of the arguments presented in Chapter 3, a type of Evolutionary Algorithm (EA), 
Cartesian Genetic Programming (CGP), was applied to the movement data of motor tasks 
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obtained from conventional clinical assessment using the Movement Disorders Society 
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (Goetz et al., 2008), as 
described in Chapter 4. The aim being to evolve diagnostic classifiers that can 
differentiate between the specified movement disorders. Movement data were provided 
by a team of clinicians and neurologists through a joint research project funded by Centre 
for Chronic Diseases and Disorders, University of York. Data collection was undertaken 
in two research centres; Leeds Teaching Hospitals NHS Trust, UK and the Monash 
Medical Centre, Melbourne, Australia. Participants in the United Kingdom were recruited 
primarily from Dr Jane Alty’s and Dr Stuart Jamieson’s consultant caseload. Both Dr Alty 
and Dr Jamieson are consultant Neurologists at Leeds Teaching Hospital NHS Trust. 
Patients recruited had an established clinical diagnosis of PD, HD and ET according to 
diagnostic criteria performed by consultants working at these centres. Healthy controls in 
this study are healthy adults with no history of a medical disorder that could affect 
movement i.e. exclusion criteria for controls include tremor, clinically diagnosed 
parkinsonism, stroke, dopamine receptor antagonists’ drugs, significant arthritis of upper 
limbs, dementia, inability to provide informed consent. In total, 27 healthy controls were 
recruited. Each participant wore electromagnetic sensors on their thumb and index finger 
and then performed three MDS-UPDRS motor tasks: finger tapping, hand pronation- 
supination and hand opening-closing, as described in Chapter 4. The recorded movement 
data was then used as inputs to train the CGP networks. Full details of the methodology 




What features of bradykinesia differentiate subjects with PD from subjects with other 




i) What are the essential differences between age-related loss of movement 
efficiency and bradykinesia in idiopathic PD? 
ii) How is the bradykinesia of PD different from other non-PD parkinsonian 
conditions such as Huntington’s disease? 
iii) Do subjects with non-parkinsonian tremulous conditions such as Essential tremor 
also exhibit bradykinesia? 
5.1 Bradykinesia in Parkinson’s Disease and healthy controls 
Using finger tapping (FT) data, Evolutionary Algorithms (EAs) have previously been 
used to evolve high accuracy classifiers that differentiate Parkinson's disease patients 
from healthy controls ( Lones et al., 2014; Smith & Timmis, 2008). Further investigation 
into the classifiers evolved was able to characterise movement disorder in PD ( Lacy et 
al., 2013) and inform clinical assessment (Lones et al., 2013). This study is extending 
these successful previous studies by using other motor tasks to evolve classifiers. Two 
additional motor tasks are hand pronation-supination (PS) and hand opening-closing 
(HO). FT data were used as a comparison and a baseline for the study. In total 26 patients 
with idiopathic Parkinson’s disease were recruited along with 27 healthy controls. 
5.1.1 CGP classification results (controls vs PD) 
As explained in Chapter 4, we used accuracy to evaluate the performance of the CGP 
classifiers. Accuracies are the prediction of the classifiers trained on an unseen data called 
the “test set”. Final accuracies in this study are the average of 10 runs where each run 
included 5 or 3 iterations of cross-validation (5-fold cross-validation or 3-fold depending 
on the number of participants available). The averaged acuracies results are reported in 
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the form of mean ± standard deviation. Both results for train and test set are present for 
each task. 
For the FT task, the final accuracy of the test set across 10 runs is 82.37%, for the 
pronation-supination (PS) task, 86.71%, and for the hand opening (HO) task, 71.19%. 
Classifiers using data from PS task achieved the highest accuracies with the best classifier  
providing an average of 96.88 %. The best classifier accuracy for the finger tapping task 
(FT) is slightly lower at 95.12%, and the best classifier accuracy for the hand opening-
closing (HO) task, is the lowest with an accuracy below 80%. Overall performance of HO 
classifiers were poor compared to the other two tasks. Best classifier and average across 
ten runs accuracies in the case of Controls vs PD of all tasks are summarised in Table 5.1. 
In Table 5.1, the result reported is in the form: mean ± standard deviation, where the mean 
and the standard deviation of the accuracies for both values of train and test set are stated. 
Averaged accuracies are visualised in Figure 5.1 to show the minimum and maximum 
performance for each task.  
 
 
       Table 5.1: Average and best accuracies of classifiers evolved for all motor tasks (controls vs PD). 




Averaged ten runs Best classifier 
Train Test Train Test 
Finger Tapping 91.64 ± 1.03 82.37 ± 2.49   93.75 95.12 
Hand pronation-supination 92.50 ± 0.65 86.71 ± 3.71 92.65 96.88 




               Figure 5.1: Averaged accuracies of CGP classifiers according to type of motor task data. 
 
5.1.2 Discriminating features 
 
The best classifier of each task was selected based on its ability to predict the class of 
unseen data in the test set. All iterations in the ten runs were considered to find which 
iteration yielded the best classifier. The best-run accuracies shown in Table 5.1 are an 
average of 5-fold cross-validation iterations. These high-performance classifiers were 
considered to identify most discriminating features of the motor task. In order to easily 
identify discriminative movement features of the best classifiers, the CGP chromosomes 
of the classifier were visualised using the open source cross-platform Graphviz utility 
(Ellson et al., 2000). The chromosomes are displayed with the inputs on the left, outputs 
on the right and the position of the internal nodes optimised by Graphviz. The function 
nodes are labelled with their functionality and given in bold if active. By looking into the 
visualised chromosome, the most discriminating features were identified. Only classifiers 
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with averaged test set accuracy higher than 80% were considered to determine the 
discriminating features. Therefore, all classifiers using HO data were not considered. 
 
Finger tapping discriminating features 
In order to verify which FT movement features make the biggest contribution in 
classifying the controls and PD groups, five FT classifiers with highest accuracies ranging 
from 88.24% to 95.12%, labelled FTPD_C1 to C5 were investigated together (Table 5.2). 
 




FTPD_C1 93.75 95.12 
FTPD _C2 91.03 93.02 
FTPD _C3 87.74 91.95 
FTPD _C4 90.68 90.12 
FTPD _C5 92.99 88.24 
 
 
In each classifier, features that were used at least once were ranked based on the number 
of times they were used. Feature with the highest number of usages were given rank 1, 
and so on (Table 5.3). If a feature was not used at all, no rank given and indicated by ‘X’. 
For each feature, the rank they get from all five classifiers were summed. By using the 
















          Table 5.3: Ranking of feature usage in five best FT classifiers for class controls vs PD. 
 
Feature 
          




C1 C2 C3 C4 C5 
(0) Cycles frequency 3 6 6 4 X X 
(1) Maximum overall amplitude 5 6 6 4 X X 
(2) Mean amplitude 4 5 X 4 1 X 
(3) Maximum overall speed 1 X X 3 4 X 
(4) Mean speed 4 6 X X 4 X 
(5) Maximum opening speed X 2 X X 4 X 
(6) Maximum closing speed 2 6 3 4 X X 
(7) Maximum opening acceleration 1 6 2 4 2 15 
(8) Maximum opening deceleration 3 6 2 4 X X 
(9) Maximum closing acceleration 3 1 1 3 X X 
(10) Maximum closing deceleration 1 6 6 1 X X 
(11) Periodicity 4 X 3 3 2 X 
(12) COV amplitude 2 6 X 4 4 X 
(13) COV speed 2 X X X X X 
(14) Decrementing amplitude 1 4 4 1 3 13 
(15) Decrementing speed 3 X 5 3 3 X 
(16) Halts 4 3 4 3 3 17 
(17) Hesitation 1 X 1 3 X X 
(18) Amp*freq 3 X X X 4 X 
 
There are only three features that were used at least once in all the five classifiers 
(highlighted in Table 5.3 ). The smaller total of rank values from all five classifiers, the 
more important the feature is. Combined rank values revealed the most important FT 
features in classifying healthy controls and PD patient (in order of importance) are as 
following: 
i. (14) Decrementing amplitude. 
ii. (7)   Maximum opening acceleration.  
iii. (16) Halts.  
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The feature that was least used in all the five classifiers is coefficient of variance (COV) 
of the speed of movement (13). Feature numbers are from Table 4.2 in Chapter 4. 
The CGP network of chromosome of the best FT classifier (FTPD_C1) is shown in Figure 
5.2. This classifier achieved 95% accuracy. The most used input by this classifier is input 
7, which is averaged maximum acceleration during opening phase of FT (refer to Section 
4.1 in Chapter 4). It is used 5 times in finding the solution. 
 
Pronation-supination discriminating features 
The top five classifiers using PS data achieved accuracies ranging from 93.75% to 96.88% 
(Table 5.4). Out of nineteen PS features, only six were used at least once by all the five 
classifiers. 





PSPD_C1 92.65 96.88 
PSPD_C2 91.67 94.44 
PSPD_C3 91.67 94.44 
PSPD_C4 90.91 94.44 
PSPD_C5 90.44 93.75 
 
Using the same method of giving ranks based on number of times a feature was used, the 
PS features that are most useful in classifying healthy controls and PD patients are as 
follows (ranked most important to least important from the top): 
i. (12) COV amplitude  
ii. (11) Periodicity  
iii. (15) Decrementing speed  
iv. (1) Mean amplitude  
v. (2) Maximum amplitude  
vi. (8) Maximum pronation deceleration  
116  
 
Figure 5.2: Visualised chromosome of the FT best classifier for the case of controls vs PD.  
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The full report on rank given to each movement feature for all five best PS classifiers is 
shown in Table 5.5. Feature numbers are from Table 4.3 in Chapter 4. 
The best PS classifier for this case of controls vs PD (labelled PSPD C1 in Table 5.4)  has 
a training accuracy of 92.65 % and predicted instances in the test set correctly at 96.88%. 
The most used features for this classifier are (12) COV amplitude and (2) mean amplitude. 
 
 
Table 5.5: Rank given to the movement features of top five best PS classifiers based on the number of times 
the feature is used in evolving the classifiers. 
Feature 
Classifier PSPD (rank) 
Total 
C1 C2 C3 C4 C5 
(0) Cycles frequency 6 X 6 3 4 X 
(1) Maximum overall amplitude 1 10 4 3 4 22 
(2) Mean amplitude 4 8 4 2 2 20 
(3) Maximum overall speed 5 7 8 3 X X 
(4) Mean speed 3 8 2 X X X 
(5) Maximum pronation speed 3 9 7 2 X X 
(6) Maximum supination speed 4 10 6 3 X X 
(7) Maximum pronation acceleration 7 2 6 X X X 
(8) Maximum pronation deceleration 7 6 3 3 2 21 
(9) Maximum supination acceleration 8 5 8 X X X 
(10) Maximum supination deceleration X 10 7 1 2 X 
(11) Periodicity 6 3 4 2 1 16 
(12) COV amplitude 2 1 3 3 5 14 
(13) COV speed 7 6 6 X X X 
(14) Decrementing amplitude 4 6 1 X 3 X 
(15) Decrementing speed 6 5 3 3 1 18 
(16) Halts 7 6 6 X X X 
(17) Hesitation 8 4 7 3 X X 
(18) Amp*freq 8 8 5 X 4 X 
 
 
5.1.3 Record-wise cross-validation 
As explained in Chapter 4, many research studies have employed record-wise cross- 
validation (cv) in order to provide more data for learning process of machine learning 
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algorithms (Saeb et al., 2017). This is especially true in clinical studies where real data 
are difficult to obtain (Forman & Cohen, 2004). We run record-wise cv in classification 
of controls and PD patients for comparison purposes and to investigate the claim that 
record-wise cv is not suitable to use in the case of medical data. We retained the same 
method of stratified k-fold cross-validation (k = 10). However, instead of making sure no 
files from the same subject appear in both training and test sets of the same fold, files 
were picked randomly regardless of subjects. Table 5.6 shows accuracies achieved by 
CGP classifiers from all three tasks using record-wise cross-validation. Using record-wise 
cv, the best classifiers for FT and PS tasks are able to classify all the instances correctly. 
HO classifiers at best can classify correctly 88% of the instances. 
 
 
                 Table 5.6: CGP accuracies using record-wise stratified 10-fold cross validation. 
                                                         Controls vs PD 
 
Task 
CGP accuracy (record-wise cv) 
10-fold average Best classifier 
train test train test 
FT 95.834 93.517 95.96 100 
PS 89.679 91.03 90.07 100 
HO 81.204 74.444 81.29 88.24 
 
Figure 5.3 showing comparison of accuracies between subject-wise cross-validation and 
record-wise cross-validation. In two out of three cases, classifiers using record-wise 
cross-validation have higher accuracies compared to subject-wise classifiers. This might 
be an indication that record-wise CV is overestimating the accuracy due to dependency 
of the training and test instances. However, the difference between the accuracies are not 
so obvious to assume that the learning process was totally bias. In fact, in case of HO 





5.1.4 SVM and ANN classifiers 
Support vector machines (SVMs) and Artificial Neural Networks (ANNs) are known for 
their ability to generate good classifiers (refer Section 3.1 in Chapter 3). These two 
machine learning methods were used to compare to the CGP classifiers.WEKA 
(Bouckaert et al., 2010), an open source machine learning workbench, was used to run 
SVM and ANN classification tasks. 
For SVM, the WEKA default algorithm that employed sequential minimal 
optimization algorithm (SMO) for training a support vector classifier was used. 10-fold 
cross-validation, and all records treated as different instances (record-wise cross- 
validation) was used. For ANN classifiers, popular feed forward backpropagations were 
used to learn a multi-layer perceptron to classify instances. Table 5.7 summarise the 
accuracies of using three types of algorithms to classify controls and PD patients. For fair 
comparison, CGP classifiers in Table 5.7 were also validated using record-wise cv. For 
FT classifiers, CGP gave the best performance at 93.51% followed by ANN classifiers 
with 87.90%, and SVM classifiers have slightly lower accuracies, 84.68%. All classifiers 
Figure 5.3 : Comparison of CGP classifiers accuracies using subject-wise and record-wise cross-
validation 
120  
using PS data showed good accuracies with around 6% difference between three types of 
algorithms (85% - 91%). HO classifiers showed poor performance, regardless of the type 
of algorithms used. CGP HO classifiers perform slightly better than both SVM and ANN 
classifiers. None of the HO classifiers reached 80%. However, the averaged accuracies 
for HO classifiers are no lower than 70%. 
                                                                       
Table 5.7: Performances of SVM and ANN classifiers for controls vs PD compared to CGP classifiers. 




CGP (record-wise cv) SVM ANN 
train test train test train test 
Finger Tapping 95.83 93.51 87.50 84.68 98.39 87.90 
Hand pronation-supination 89.67 91.03 88.10 86.90 98.80 85.1 
Hand opening-closing 81.20 74.44 75.58 69.77 76.16 73.26 
 
The comparison between test set accuracies of each algorithm is visualised in following 
Figure 5.4. 
 
             Figure 5.4 : Comparison between performance of different algorithms for Controls vs PD. 
 




FT kinematic data have been used many times to distinguish healthy controls and PD 
patients. Indeed, some studies also used CGP in differentiating these two groups ( Lacy 
et al., 2013;  Lones et al., 2013; Lones et al., 2014). However, FT data were investigated 
again in this study, but for the purpose of validating the method used, as we extend the 
study to other motor tasks and later other groups of movement disorders. At 80% and 
above, the results of this study showed accuracies achieved by the FT classifiers are 
comparable to results from the previous FT (using CGP, SVM and ANN) studies ( Lacy 
et al., 2013; Lones et al., 2013; Lones et al., 2014; Martinez Manzanera et al., 2015; Picardi 
et al., 2010). The important finding in the FT results is that the most discriminating FT 
features did demonstrate the method used in this study is applicable. The results report 
that the most discriminating FT feature is ‘decrementing amplitude’, an accepted 
characteristic of Bradykinesia (Fernandez et al., 2014). The second most important FT 
feature is ‘opening acceleration‘, and has similarity with findings in Yokoe et al. (2009), 
where they claimed opening velocity as a novel parameter in differentiating PD patients 
movement from healthy old people. The third most discriminating feature, ‘halts’ might 
be an important feature that was known but not deemed important before. 
Subsequently, the same bradykinesia features used as input to FT classifiers were 
applied to hand pronation-supination (PS) data by replacing opening phase with 
pronation, and closing phase with supination movement. PS classifiers reached accuracies 
even better than FT classifiers and lead to several important features that might not have 
been given sufficient attention before. This is especially true because there have not been 
as many PD objective assessment studies where PS kinematic data is compared to FT. 
Whilst rhythm and periodicity of amplitude are not important to the FT task, they are the 
most discriminating features of PS.  
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Pronation-supination itself is a rhythmic movement; it is a motor task that is 
commonly used to test the ability of executing diadochokinetic movements. 
Diadochokinesia is ability to perform rapid, alternating movements (RAM), capability to 
cease current movement and start the opposite movement instantly after that. The 
assessment of ability to perform RAM can provide important information about the 
condition of the nervous system. Unfortunately, a significant amount of information can 
be lost during the clinical test where qualitative rating scales are used instead of 
quantitative assessment. The abnormality of diadochokinesia can be seen in the 
completeness of the sequence, and in the variation of amplitude. Furthermore, two other 
amplitude characteristics of PS, namely mean and maximum amplitude of both phases, 
are also deemed as important distinguishing features. The smaller amplitude means 
subjects did not get to finish the phases (of pronation or supination). The high accuracies 
of PS classifiers indicate that there is a significant difference between the way healthy old 
people and PD patients execute RAM such as hand pronation-supination. HO classifiers 
performance in the controls vs PD case is not very encouraging compared to the other 
two tasks. However, the accuracies are not so low that the classifications are unuseful. 
This may be due to the different nature of movement of HO; unlike FT and PS, HO 
involves two steps movement where thumb and fingers move at different phases. Hence, 
there are possibilities the same method of data collection and features extraction cannot 






5.2 Bradykinesia in Parkinson’s disease and Huntington’s disease 
The majority of previous quantitative studies to measure the existence of Bradykinesia in 
Huntington’s disease (HD) focused on slowness of movement (refer section 2.5 in 
Chapter 2). Bradykinesia itself is not purely slowness, but is a complex disturbance of 
initiation and execution of actions and the ability to sustain them. Akinesia (failure to 
initiate movement) and hypokinesia (underactive movement) both relate to bradykinesia, 
as does the sequence effect—repetitive movements becoming smaller or slower. This part 
of study observed characteristics of Bradykinesia in Huntington’s disease (HD) compared 
to Parkinson’s disease (PD) and healthy old people (controls). As described in Chapter 4, 
three motor tasks were used, finger tapping (FT), hand opening-closing (HO) and hand 
opening-closing (PS). Eleven HD patients recruited for this study; however not all of them 
were able to finish all the three tasks. Table 5.8 lists the number of subjects for each group 
for different motor tasks. 
 
 
         Table 5.8: Numbers of healthy controls, PD and HD patients performed different motor tasks. 
Task Controls PD HD 
Finger tapping 27 26 11 
Hand pronation-supination 27 26 6 
Hand opening-closing 27 26 10 
5.2.1 CGP classification results 
Classifiers were evolved using the same method as described in Chapter 4. Two cases 
were considered, healthy controls vs Huntington’s disease patients (controls vs HD) and 
Parkinson’s disease vs Huntington’s disease (PD vs HD). Table 5.9 presents classification 
accuracies of controls vs HD for all three tasks in the form: mean ± standard deviation for 
both values of train and test set . The averaged accuracies are visualised in Figure 5.5 with 
mean, maximum and minimum accuracy plotted.                                                         
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                                            Table 5.9: Accuracies for classifiers of controls vs HD. 





Averaged ten runs Best classifier 
Train Test Train Test 
Finger Tapping 92.36 ± 1.19 83.42 ± 2.11 91.41 91.38 
Hand pronation-supination 93.61 ±1.06 85.98 ± 1.85 92.39 95.83 




                          Figure 5.5: CGP Accuracies averaged across ten runs for case controls vs HD. 
 
 
For the finger tapping task, accuracy of the test set across 10 runs for controls vs 
HD is 83.42 %. Slightly higher accuracy was obtained for PS classifiers at 85.98%. HO 
classifiers, as in case of controls vs PD, is still showing poor performance with only 
76% accuracy. Overall performance of all classifiers shows that the selected Bradykinesia 
features are able to differentiate HD from healthy controls. In other words, it can be 
hypothesised that Bradykinesia does exist in Huntington’s disease. 
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The following results provide information on whether Bradykinesia features in HD have 
the same characteristic as the features in PD patients’ movement. The summary of the 
classifier’s accuracies for PD vs HD is given in Table 5.10 in the form: mean ± standard 
deviation for both values of train and test set. The averaged accuracies are visualised in 
Figure 5.6 for comparison of CGP classifiers according to motor tasks.   
                                                                 
                                       Table 5.10: Accuracies for CGP classifiers of PD vs HD. 
                                                                     PD vs HD 
 
 





Averaged ten runs Best classifier 
Train Test Train Test 
Finger Tapping 85.47 ± 1.19 67.97 ± 2.95 83.67 80.95 
Hand pronation-supination 95.65 ± 0.85 87.20 ± 1.91 94.19 95.45 
Hand opening-closing 93.38 ± 1.19 84.81 ± 3.73 90.28 97.22 
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The best classifiers for PD vs HD case were evolved using kinematic data from 
the pronation-supination task (PS), with an averaged accuracy of 87.20%. FT classifiers 
did not show a good performance in differentiating PD from HD. In previous cases, the 
majority of HO classifiers achieved lower accuracies below 80%, but in the case of HD 
patients, HO classifiers obtained high accuracies of 85% for the PD vs HD case. This 
indicates that although HO movement features cannot reliably distinguish healthy 
controls from PD and HD, it can recognise HD very well when compared with PD 
patients. It is therefore interesting to determine which HO features evolved the best HO 
classifiers for class of PD vs HD. 
5.2.2 Discriminating features 
In the case of PD vs HD, both HO and PS classifiers achieved very good accuracies. 
However, the number of HD patients is higher for the HO task compared to participants 
that completed the PS task, giving more confidence in the results. Focusing on the 
potential of HO data in the classification of PD and HD patients, strong discriminative 
features have been noted. Table 5.11 shows the number of times every HO movement 
feature was used in evolving the best HO classifier for PD vs HD. This classifier has 
accuracy of 97%. CGP network of the chromosome for this classifier is visualised in 
Figure 5.7 where it can be seen that input number (6) and (3) were used repeatedly in 
finding the solution, which indicates that features ‘thumb maximum deceleration’ and 
‘thumb maximum speed’ are among most discriminative features in this classification. 
Other important features are (0) ‘maximum opening’, ‘COV of speed’ for (7) thumb sensor 




                       Table 5.11: Best HO classifier discriminating features for PD vs HD case. 
Feature Number of times used 
Maximum opening 6 
COV opening 2 
HO frequency 3 
TS maximum speed 6 
TS average speed 3 
TS maximum acceleration 3 
TS maximum deceleration 8 
TS COV speed 6 
TS Halts 1 
FS maximum speed 5 
FS average speed 5 
FS maximum acceleration 5 
FS maximum deceleration 3 
FS COV speed 6 
FS Halts 6 
 
5.2.3 SVM and ANN classifiers 
In this section, comparisons are made between accuracies of the CGP classifiers with 
popular algorithms ANN and SVM. The parameters for ANN and SVM are as explained 
in Section 5.2.4. Two cases were considered, controls vs HD and PD vs HD. The results 
for all three types of classifiers are shown in Table 5.12 for controls vs HD. For fair 
comparison, CGP classifiers in the table used record-wise cv. It can be seen in the table 
that for the case of controls vs HD, ANN gained high accuracies in all tasks. In fact, using 
PS kinematic data, ANN get 100% accuracies predicting classes of instances in the test 
set. Results of SVM are comparable to CGP except for SVM PS classifiers where the 
accuracy is nearly 100%. Overall, the same patterns are shown by ANN and SVM where 
the highest accuracies achieved for PS, followed by FT and lowest accuracies for HO. 
This can be argued to validate the CGP results because the same ranking of accuracies is 
also shown by CGP.                                                        
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Table 5.12: Accuracies of classifiers evolved using CGP and two other popular algorithms, SVM and ANN 
in classification of healthy controls vs Huntington’s disease patients. 




CGP (record-wise CV) SVM ANN 
train test train test train test 
Finger Tapping 92.36 84.87 88.02 86.98 99.48 84.38 
Hand pronation-supination 100 100 100 99.04 100 100 
Hand opening-closing 88.33 81.67 84.17 77.5 90 80.83 
 
In PD vs HD case, the same pattern of performance is shown by all classifiers where 
highest accuracies were obtained by PS classifiers, followed by HO and lowest accuracies 
by FT classifiers. CGP gained comparable results to SVM and ANN for all tasks (Table 
5.13). As in previous cases, PS classifiers (for all three algorithms considered) showing 
the best performance. Poor performance by FT classifiers evolved using CGP are also 
reflected in ANN and SVM FT classifiers with most of classifiers obtaining accuracies 
below 70%. As described in Section 5.3.1, surprisingly, CGP evolved HO classifiers with 
high accuracies for the PD vs HD case. Similar results were gained by ANN HO 
classifiers. However, SVM HO classifiers do not show good results, with accuracy below 
80%. This suggets ANN and CGP were learning characteristics that were missed by SVM.                                                                    
 
Table 5.13: Results of classification accuracies using ANN and SVM algorithms compared to accuracies 
of classifiers evolved using CGP for PD vs HD case. 




CGP (record-wise CV) SVM ANN 
train test train test train test 
Finger Tapping 83.176 78.57 74.29 72.14 95 66.43 
Hand pronation-supination 99.602 98.258 100 98.21 100 97.32 
Hand opening-closing 88.637 87.255 79.55 77.27 91.67 84.09 
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                                                       Figure 5.7: Visualised chromosome of the best classifier for PD vs HD class using HO data .
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5.2.4 Discussion 
FT as a popular task in machine learning classification, which in this work shows 
expected results of high accuracies in the case of controls vs PD. However, in HD study, 
compared to HO and PS classifiers, FT classifiers achieved the lowest accuracy when 
used to differentiate between PD and HD groups. This suggests that selected bradykinesia 
features in FT are not strong discriminative characteristics of PD and HD patients. PS 
classifiers continue to consistently achieved high accuracies in HD cases, but the low 
number of HD patients used in the PS task lessens the confidence in the PS classifiers 
accuracies. 
This is the first time CGP was applied in classifying other movement disorders (apart 
from PD) using kinematic data of common clinical motor tasks. Both HO and PS achieved 
very good accuracies for the PD vs HD case. Focusing on the potential of HO data in 
classification of HD patients, discriminative features have been noted. The best HO 
classifier (PD vs HD) used the ‘thumb sensor (TS) maximum deceleration’ feature eight 
times in finding the solution. Other important discriminative features are ‘maximum 
opening (0)’, ‘COV of speed’ for the thumb sensor (7) and finger sensor (13) and ‘halts’ 
(14). The results suggest that bradykinesia features in healthy old people, PD and HD 







5.3 Bradykinesia in Parkinson Disease and Essential Tremor 
The objective of this part of the study is to identify the existence of Bradykinesia in 
Essential tremor (ET). Although ET has been repeatedly mistaken for PD and vice-versa, 
the symptom perceived as the cause of the confusion is tremor instead of slowness. 
However, as mentioned at the beginning of this chapter, a few studies found slowness in 
ET patients compared to healthy old people. If Bradykinesia does exist in ET, then it is 
important to know if Bradykinesia in ET has the same characteristics as in PD. In pursuit 
of this, kinematic data of six ET patients was collected for preliminary experiments. Using 
extracted data of the three motor tasks from the MDS_UPDRS, classification using CGP, 
SVM and ANN were run for two cases: controls vs ET and PD vs ET. 
5.3.1 CGP classification results 
Table 5.14 shows classification accuracies of controls vs ET for all three tasks. The 
averaged accuracies are visualised in Figure 5.8 with mean, maximum and minimum 
accuracy plotted. It can be seen that the same pattern as seen in controls vs HD had 
reoccurred where the best performance was shown by PS classifiers with an averaged 
accuracy of 98.77% followed by FT classifiers with 85.99% accuracy and 78.47% 
accuracy for HO classifiers.                                                         
 
                      Table 5.14: Accuracies for CGP classifiers for the case of controls vs ET. 




Averaged ten runs 
Train Test 
Finger Tapping 95.28 ± 1.01 85.99 ± 1.70 
Hand pronation-supination 100.00 ± 0 98.77 ± 1.42 
Hand opening-closing 92.09 ± 1.82 78.47 ± 3.19 
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               Figure 5.8: CGP Accuracies averaged across ten runs for case controls vs ET. 
 
In the case of PD vs ET, PS classifiers correctly classified 90% of the instances in their 
correct classes (Table 5.15). In both Table 5.14 and Table 5.15, the result reported is in 
the form: mean ± standard deviation, where the mean and the standard deviation of the 
accuracies for both values of train and test set are stated. Although the other two tasks 
only evolved classifiers with accuracies ranging from 75% to 79%, with a higher number 
of ET participants better performance of FT classifiers might be expected. The 
performance of all classifiers across 10 runs are visualised in Figure 5.9. 
 
Table 5.15: Accuracies for CGP classifiers of the case of PD vs ET 
 




Averaged ten runs 
Train Test 
Finger Tapping 91.43 ± 1.57 78.59 ± 2.81 
Hand pronation-supination 97.73 ± 1.44 88.94 ± 2.57 
Hand opening-closing 91.89 ± 1.08 75.00 ± 4.09 
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                            Figure 5.9 : CGP Accuracies averaged across ten runs for case PD vs ET. 
 
 
5.3.2 SVM and ANN classifiers 
In the case of controls vs ET, CGP classifiers performed better than SVM and ANN in all 
motor tasks. It is argued this is due to CGP’s better capabilities of finding connection 
between instances of the same subject as record-wise cv is used here. CGP PS classifiers 
classify all instance in the correct classes. Very small differences in performance are 
achieved by CNN and SVM at 97% and 98% accuracies, respectively. HO classifiers 












Table 5.16: Performance of CGP, SVM and ANN in classification of controls vs ET. 
 





CGP (record-wise CV) SVM ANN 
train test train test train test 
Finger Tapping 92.59 89.71 87.9 85.06 94.83 86.21 
Hand pronation-supination 100 100 98.08 98.08 100 97.12 
Hand opening-closing 87.50 81.001 79.81 76.92 86.54 79.81 
 
In the case of PD vs ET, ANN induced the best classifiers in two out of three motor tasks. 
Only in case of HO classifiers, CGP performed better. In almost all motor tasks, SVM 
performances are in between of CGP and ANN. 
 
Table 5.17: Performance of CGP, SVM and ANN in classification of PD vs ET. 
 





CGP (record-wise CV) SVM ANN 
train test train test train test 
Finger Tapping 88.52 83.653 81.15 80.33 99.18 90.16 
Hand pronation-supination 97.82 91.213 91.96 91.07 100 96.43 
Hand opening-closing 88.41 79.224 80.43 78.26 100 76.09 
5.3.3 Discussion 
Although the number of ET participants in this study is small, the same pattern of 
performance between motor tasks (with our studies with higher number of participants; 
controls vs HD, controls vs HD) indicates that the results of this study can be used to 
argue the existence of Bradykinesia in ET. High-performance classifiers of three 
algorithms; CGP, SVM and CGP in differentiating ET from healthy controls supports the 
argument that Bradykinesia features exist in ET. Bradykinesia is not the main source of 
confusion between PD and ET, but this study indicates that by using Bradykinesia 
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features, CGP and other machine learning algorithms managed to perform well in 
differentiating the two disorders. This suggests that the two disorders have different 
characteristics in their bradykinetic features. 
5.4 Conclusion 
Each classification in this study plays an important role in the characterisation of 
Bradykinesia in PD, HD and ET. Most previous machine learning studies on PD motor 
symptoms focus on classifying PD patients from healthy controls, as reviews on machine 
learning classification of PD testify (Ahlrichs & Lawo, 2013). Yet, to address the problem 
of misdiagnosis, the real challenge is to differentiate between groups of different 
movement disorders and observe the discriminating features. FT as a popular task in 
machine learning classification shows expected results of high accuracies in case of 
controls vs PD. The overall accuracy was lower than shown in previous studies of CGP 
classifications using finger tapping data (Lacy et al., 2013; Lones et al., 2014), but it is 
suggested that this is due to smaller numbers of subjects in this study. One of the original 
intentions of this study was to extend usage of finger tapping (in classification of PD) to 
other motor tasks. Clearly the results in controls vs PD case show that the PS task can 
also be used for this purpose. Although HO classifiers accuracies are not as encouraging 
compared to the other two tasks, the performance is the classification is still quite good. 
Most HO classifiers achieved accuracies above 70%. 
The most interesting cases in this study are regarding HD patients. This is the first 
time CGP was applied in classifying other movement disorders (apart from PD) using 
kinematic data in common clinical motor tasks. PS and HO classifiers achieved very good 
accuracies for the HD cases. The fact that HD patients can be differentiated from healthy 
control using extracted Bradykinesia features supports the argument that Bradykinesia 
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does exists in Huntington’s disease. In the case of PD vs HD, both PS and HO classifiers 
show good accuracies, but with higher number of participants in HO tasks giving more 
confidence to HO classifiers compared to PS classifiers. Hence, the focus of investigating 
discriminating features (of PD vs HD case) was given to HO classifiers. Several HO 
movement features were highlighted as strong discriminative features for PD vs HD 
cases. Among the most important HO features are the speed of thumb movement during 
the slowing down process and the rhythm of speed of the thumb and fingers during hand 
opening and closing. Another exciting finding is that classifiers evolved using pronation- 
supination data not only achieved comparable accuracy with FT classifiers in all cases 
but are able to classify better in many cases. This implies that features of bradykinesia in 
PS movement have highly distinguishing characteristics between the classes (controls, 
PD and HD). Surprisingly, FT classifiers achieved low accuracy for PD vs HD cases. 
This suggests that selected bradykinesia features in FT are not the most distinctive 
characteristics of PD and HD patients. 
The second study of other movement disorders (than PD) involved patients of 
Essential Tremor. Only six ET patients were available, but sufficient to provide some 
insights on Bradykinesia in ET. High-performance PS and ET classifiers of three 
algorithms, CGP, SVM and CGP, in differentiating ET from healthy controls, suggest 
that Bradykinesia features exist in ET. Bradykinesia is not the main source of confusion 
between PD and ET, but this study indicates that by using Bradykinesia features, CGP 
and other machine learning algorithms managed to perform well in differentiating between 
the two disorders. It is suggested that the two disorders have different characteristics of 
bradykinetic features but a higher number of participants can confirm this. 
All the CGP results were validated by comparing them to results obtained using widely 
adopted machine learning algorithms, SVM and ANN. It is the common practice in 
statistical machine learning to perform classification by random instances divided into 
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training and test sets without consideration of the instances (records) belonging to the 
same participant or not (record-wise cv). Therefore, to obtain results that can be compared 
with previous studies, record-wise cv was used to compare the three algorithms (CGP, 
ANN and SVM) performances. The results show that the same pattern of performance 
were demonstrated by SVM and ANN as in CGP classifiers. For example, in the controls 
vs PD case, the best CGP classifiers were evolved using PS kinematic data, followed by 
FT classifiers and lowest accuracies obtained by HO classifiers. This ranking of 
performances also shown by SVM and ANN, validate the CGP results. Overall, CGP 









                                                              
Differentiation of Organic and Functional Dystonia 
In 2013, an international Consensus Committee, consisting of investigators with years of 
experience in dystonia agreed to proposed revised definition of dystonia as following 
(Albanese et al., 2013) : 
• Dystonia is a movement disorder characterized by sustained or intermittent 
muscle contractions causing abnormal, often repetitive, movements, postures, or 
both. 
• Dystonic movements are typically patterned, twisting, and may be tremulous. 
• Dystonia is often initiated or worsened by voluntary action and associated with 
overflow muscle activation 
 
Currently, there is no known cure for Dystonia, but effective treatments, coping 
strategies and support are available. In most cases, dystonia does not shorten a person's 
lifespan. Historically, Dystonia lacked unifying criteria to put it under a type of disorder; 
it is not until late 1970’s that Dystonia was recognised as its own class of movement 
disorder. Before that, generalised Dystonia have been managed along the psychiatric line, 
viewed as not organic disorders (Newby et al., 2017). After Dystonia was recognised as 
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a class of movement disorder, the psychiatric part of Dystonia still remained, it is known 
as Psychogenic Dystonia and later renamed to Functional Dystonia (FD). Functional 
dystonia is a condition where some specific symptoms of dystonia appear, but tests that 
normally establish the cause of these symptoms are negative. It is part of what is known 
as Psychogenic Movement Disorders (PMDs). PMDs can look like any organic 
neurologic condition, but it has a psychiatric cause. A variety of blood, imaging and other 
tests are usually normal and do not reveal any physical (organic) cause that could explain 
these motor abnormalities. Functional dystonia is arguably the most challenging 
functional movement disorder to diagnose and manage. It is especially difficult to 
differentiate FD from its organic version, Organic Dystonia (OD). Consequently, delays 
in diagnosis and treatment initiation have a negative impact on outcome, increasing the 
risk of long-term disability and the resulting financial burden on society. Hence, there is 
a growing emphasis on the need for ‘laboratory supported’ criteria, based on objective 
measurements of movement vectors and/or muscle activity. In order to support this need, 
this study was designed for objective assessment using evolutionary algorithm by 
application of classification task between organic and functional dystonia. 
6.1 Types of Dystonia 
Classification of Dystonia can be made along several dimensions. Among important 
dimensions or axes include body distribution, age onset, and cause of the dystonia. (Geyer 
& Bressman, 2006). In details, dystonia experts consensus suggested classification 
according to recognised using two axes (Albanese et al., 2013): 
Axes 1: clinical characteristics 




6.1.1 Axes 1: Clinical characteristics 
The clinical characteristics describe the phenomenology of dystonia in a given patient. 
Descriptors that can be used to specify clinical characteristics: 
 
i. Age at onset 
• Infancy dystonia (birth to 2 years) 
• Childhood dystonia (3–12 years) 
• Adolescence dystonia (13–20 years) 
• Early adulthood dystonia (21–40 years) 
• Late adulthood dystonia (>40 years) 
 
ii.  Body distribution 
Body regions involved by dystonia are the upper or lower cranial region, the cervical 
region, the larynx, the trunk, the upper or lower limbs. These different territories may be 
involved individually or in different combinations. 
 
Focal. Only one body region is affected. Typical examples of focal forms are 
blepharospasm, oro-mandibular dystonia, cervical dystonia, laryngeal dystonia, and 
writer’s cramp. Cervical dystonia is considered a form of focal dystonia, although by 
convention the shoulder can be included as well as the neck. 
 
Segmental. Two or more contiguous body regions are affected. Typical examples of 
segmental forms are cranial dystonia (blepharospasm with lower facial and jaw or tongue 
involvement) or bi-brachial dystonia. 
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Multifocal. Two non-contiguous or more (contiguous or not) body regions are involved. 
 
Generalized. The trunk and at least two other sites are involved. Generalized forms with 
leg involvement are distinguished from those without leg involvement. 
 
Hemidystonia. More body regions restricted to one body side are involved. 
Typical examples of hemidystonia are due to acquired brain lesions in the contralateral 
hemisphere. 
 
iii. Temporal pattern 
Disease course can be either static or progressive. The variability can have four different 
patterns: 
Persistent. Dystonia that persists to approximately the same extent throughout the day. 
Action-specific. Dystonia that occurs only during a certain activity or task. 
Diurnal fluctuations. Dystonia fluctuates during the day, with recognizable circadian 
variations in occurrence, severity and phenomenology. 
Paroxysmal. Sudden self-limited episodes of dystonia usually induced by a trigger with 
return to pre-existing neurological state. 
 
iv. Coexistence of other movement disorders 
Isolated dystonia. Dystonia is the only motor feature, with the exception of tremor. 
Combined dystonia. Dystonia is combined with other movement disorders (such as 







v. Other neurological manifestations. 
The presence or absence of other neurologic or systemic features is a vital component for 
characterizing dystonia syndromes. Wilson disease is a disorder where dystonia is 
typically combined with other neurological or psychiatric symptoms and liver disease 30. 
The broad neurological spectrum evolves over time, with frequent revisions as new 
information is gained. 
 
Axes 2: aetiology —although there is effort to redefine the categories of Dystonia 
regarding the causes (Albanese et al., 2013), the still popular etiologic classification 
divide Dystonia into two broad categories: primary (idiopathic; without no known cause) 
and secondary (symptomatic) (Albanese & Jankovic, 2012). Primary and secondary 
Dystonia according to (Geyer & Bressman, 2006) are as following: 
 
Primary Dystonia 
In primary dystonia, no abnormality other than dystonia is present, apart from the 
occasional occurrence of tremor (resembling essential tremor) or myoclonus. Findings 
such as parkinsonism, seizures, dementia, ataxia, ocular motor abnormalities, weakness, 
or spasticity suggest that dystonia is secondary. Moreover, when tremor or myoclonus 
accompanies primary dystonia, these associated movements are less prominent than the 
dystonia. If these movements predominate, a secondary dystonia is likely. In primary 
dystonia, there are no structural brain abnormalities on radiographic studies and no inborn 
errors of metabolism identifiable with conventional investigations. Most primary 
dystonias are focal or segmental in distribution, with onset in adulthood. Around 10% of 




When dystonia is secondary to a hereditary neurological disorder or an exogenous insult, 
additional neurological abnormalities are likely to be present. An important exception is 
dystonia resulting from dopamine receptor blocking agents (acute dystonic reaction and 
tardive dystonia), which usually consists of dystonia only. One subcategory of secondary 
dystonia comprises the dystonia-plus syndromes. In these inherited disorders, dystonia is 
accompanied by other neurological abnormalities, but like in the primary dystonias, there 
is no evidence of brain degeneration. The dystonia-plus syndromes include dopa- 
responsive dystonia, myoclonus- dystonia, and rapid-onset dystonia-parkinsonism 
6.2 Organic and Functional Dystonia 
Classification of Dystonia as in Section 6.1 is describing the ‘real’ or Organic Dystonia 
(OD). When a patient showing some specific symptoms of dystonia appear, but tests that 
normally establish the cause of these symptoms are negative, it is what is known as 
Psychogenic or Functional Dystonia (FD). It is part of what is known as Psychogenic 
movement disorders (PMDs). Most psychogenic movements are considered involuntary 
– performed without conscious awareness or effort. Other types of PMDs include 
Psychogenic tremor (also called functional tremor), Psychogenic parkinsonism and 
Psychogenic gait disturbances. 
6.2.1 Diagnosis of Organic and Functional Dystonia 
 
The diagnosis of dystonia, like that of all neurological disorders, rests most firmly on the 
history and physical examination. A clinical diagnosis of OD is made through recognition 
of its core motor features and their distribution and temporal evolution. Non-motor 
features include disturbed sensory and cognitive processing and psychiatric features 
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(Albanese et al., 2013). A complex interplay between motor, sensory and limbic centres 
may give rise to odd and atypical features (e.g. task-specificity, geste antagonist), 
potentially misleading the inexperienced clinician. The resulting misdiagnosis rate is 25- 
52% (Stamelou et al., 2012). 
On the other hand, a diagnosis of FD rests on assessment of inconsistency and 
incongruence (in both the history and neurological examination) with organic disease 
patterns (Espay & Lang, 2015; Ganos et al., 2014). Functional dystonia is arguably the 
most challenging functional movement disorder to diagnose and manage. Current 
diagnostic criteria place disproportionate weight on features with poor predictive value: 
historical features (such as sudden-onset or stress-induced symptoms) and psychiatric 
comorbidity, which are also prevalent in organic dystonia. Consequent delays in diagnosis 
and treatment initiation have a negative impact on outcome, increasing the risk of long-
term disability and the resulting financial burden on society. Hence there is a growing 
emphasis on the need for ‘laboratory supported’ criteria, based on objective 
measurements of movement vectors and/or muscle activity. 
6.3 Classification of organic and functional Dystonia using EA 
Research to date has shown that diagnostic criteria for FD have poor inter-rater reliability 
(Ganos et al., 2014) placing emphasis on historical variables and/or psychiatric 
comorbidity, which have poor predictive value. The need for ‘laboratory supported’ 
criteria for FD, based on electrophysiological signifiers, has been highlighted (Espay & 
Lang, 2015). Such criteria would permit earlier diagnosis and treatment, reducing the risk 
of long-term disability and the accompanying health and social care costs (the estimated 
UK cost for all ‘medically unexplained symptoms’ being £18 billion) (Hons et al., 2010) 
In previous quantitative studies, characteristics of Bradykinesia such as variability 
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(coefficient of variation), rhythm and slowness while performing finger tapping test were 
found as indications of malingering or psychogenicity (Arnold et al., 2005; Kalogjera- 
Sackellares & Sackellares, 1999; Rapport et al., 1998). For example, tapping was less 
rhythmic with higher variability in both malingering and psychogenic disorders. Subjects 
with suspected malingering performed the finger tapping more slowly than their 
comparison group counterparts regardless of the type of neurological diagnosis. Objective 
assessment studies differentiating organic and functional disorders are not common 
(Criswell et al., 2010). In fact, there are no studies that we know of trying to objectively 
differentiate FD and OD using kinematic data of any motor task. Based on these facts, 
this study employed Cartesian Genetic Programming for classification of organic 
dystonia, functional dystonia and healthy controls using movement data of finger tapping 
task as the input. The method of movement data collection, data processing and 
classification steps explained in Chapter 4. However, there is a slight change made for 
Dystonia study in term of movement data collection method. In PD study (as described 
in Chapter 4), participants executed finger tapping for ten times as suggested by MDS-
UPDRS with two repetitions for each hand. However, in this study, participants tap their 
fingers for 15 seconds. There are three repetitions for each hand which means, for each 
participant, six finger-tapping movement recordings were obtained. There are altogether 
29 healthy controls, 31 Organic Dystonia and 12 Functional Dystonia patients. 
Participants with dystonia were recruited from the current caseloads of the 
movement disorders consultants at Monash Medical Centre in Melbourne (Australia) and 
Leeds General Infirmary, Leeds, UK. Assessments took place between September 2015 
and February 2018. Ethical approval was obtained from the Monash Health Human 
Research Ethics Committee (HREC code: 13424B) and the Yorkshire and Humber 
Sheffield Research Ethics Committee (HREC code: 14/YH/0143).  
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Patients and controls subjects were chosen following the three inclusion criteria: 
 
i. Organic dystonia: Expert diagnosis, according to accepted guidelines, with 
upper limb or cervical involvement (genetic, idiopathic focal or secondary); 
ii. Functional Dystonia: Expert diagnosis, documented or clinically established 
according to the Fahn-Marsden criteria, with upper limb involvement; 
iii. Controls: Capacity to consent and able to perform assessments. Control 
subjects were recruited from spouses and friends of the patients who attend 
clinics at the Monash Medical Centre. 
 
Subjects were removed from the study according the following exclusion criteria: 
- Aged under 18 years; 
- Lacking capacity to consent; 
- Unable to perform movement assessments (e.g. due to cognitive deficit).  
6.3.1 CGP classification results 
 
CGP classifiers were evolved using the same method described in Chapter 4 using 
movement data from the MDS-UPDRS defined finger tapping task. Three cases of 
pairwise classification were considered: 
• Controls vs OD 
• Controls vs FD 
• OD vs FD 
 
Table 6.1 shows classification accuracies of all the three cases in the form: mean ± 
standard deviation, where the mean and the standard deviation of the accuracies for both 
147  
values of train and test set are stated. The averaged accuracies across ten runs and the 
accuracies of the best run is visualised in Figure 6.1 with mean, maximum and minimum 
accuracies plotted.  
 
 
Table 6.1: CGP classifiers accuracies for all three cases of pairwise classification considered: Con vs OD, 





Averaged ten runs Best run 
Train Test Train Test 
Finger Tapping 64.30 ± 0.62 60.12 ± 3.19 65.55 64.58 
Hand pronation-supination 83.84 ± 0.97 74.33 ± 2.55 85.62 77.00 





Figure 6.1: CGP accuracies averaged across ten runs for compare according to classification cases 
considered 
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None of the CGP classifiers evolved in any of the cases, achieved an accuracy beyond 
80%. The classification for the case between controls and OD patients has the worst 
accuracies, with some of the CGP classifiers with accuracies below 55%. A better 
performance is shown by classifiers evolved for the case of controls vs FD, achieving 
results as high as 77% accuracy. Surprisingly, the case that is considered most challenging 
to diffrentiate, OD vs FD, achieved accuracies ranging from 68% to 77%. The best-run 
accuracies do not show any vast difference from the averaged values. 
6.3.2 Comparison with SVM and ANN 
Comparisons were made between accuracies of CGP classifiers and popular machine 
learning algorithms; SVM and ANN. SVM and ANN parameters used in this study 
discussed in Section 5.2.4 of Chapter 5. 
 





CGP (best run) SVM ANN 
train test train test train test 
Controls vs OD 65.55 64.58 66.10 64.41 89.55 66.95 
Controls vs FD 85.62 77.00 77.92 75.00 93.33 68.75 
OD vs FD 83.78 72.49 78.00 66.81 84.00 62.92 
 
In all cases, results using CGP and other algorithms are comparable with very small 
differences between each other. ANN shows signs of overfitting where the accuracies of 
the training sets were much higher than the those of the test set. 
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6.4  Discussion 
It is a known fact that diagnosis of FD is very difficult. It might be the main reason for 
poor performance of all machine learning algorithms applied in this study. The fact that 
all three algorithms, CGP, SVM and ANN, produced comparable results demonstrates 
that the problem is with the data rather than the method applied. 
There are several possible reasons why the data is unreliable. The problem might be with 
regard to the selected motor task. Although a few previous studies using finger tapping 
data of Psychogenic Movement Disorders (PMD) shows significant difference between 
PMD and healthy controls, the studies did not specifically address Functional Dystonia. 
The movement characteristics of Functional Dystonia and other PMDs might be different. 
The second reason might be the participants. Dystonia patients in this study consists of 
various subtypes of Dystonia. Although all Dystonia participants have affected upper 
limb movements, the symptoms might not be shown in the hand only. In future it is 
suggested that the use of a combination of motor tasks is considered that involve other 
affected body parts as well. The third problem might be in number of instances available. 
The number of participants in the Dystonia study is good compared to PD study. 
However, due to the high variation of symptoms in Dystonia patients, the study needs 
more participants for the algorithms to better predict these. 
The differentiation of PMD from its organic version is very important to support 
the clinical diagnosis. The misdiagnosis rate is too high for the costs to be ignored. 
Therefore, it is suggested that this study be continued but by looking into different 









                                                              
Conclusions and future works 
In this chapter, a summary of the whole study is presented, stating the findings deemed 
important and suggestions for future work. Finally, the hypothesis and objectives of the 
study stated in Chapter 1 are revisited. 
7.1 Research summary 
The real-world aim of this study is towards improving diagnosis and monitoring of 
neurological conditions, particularly the conditions that cause movement disorders. 
Neurological conditions are the biggest caused of loss of healthy life in the world 
population. The main motivations for this study stem from the multiple impacts of 
movement disorders to the life of patients, family, society and a country’s economy. The 
symptoms of the condtions cause a decrease in quality of life (QOL) in many ways 
including loss of independence, negative impact on relationships and work, and having 
difficulties performing day-to-day activities (Dowding et al., 2006; Soh et al., 2013; 
World Health Organization, 2006). The disorders affected QOL not only of the patients 
but the caregivers as well (Carter et al., 2008; Martínez-Martín et al., 2005, 2007). The 
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degrading quality of life of patients and caregivers is especially true for 
neurodegenerative disorders such as PD and HD where the burden increase as the disease 
progress. The economic cost of movement disorders is high, involving public health 
activities that include formal health care such as personal medical attention, home care 
and self-care, health promotion and disease prevention (World Health Organization, 
2006). The effect is big and global. In 2005, over one million people in Europe were 
diagnosed with Parkinson’s disease, with around 127000 of them living in the United 
Kingdom. It is projected that the number will double by 2030 (Dorsey et al., 2007). 
Approximately 2.2% of the US population have essential tremor, smoe 6.38 to 7.63 
million people (Louis & Ottman, 2014). Until now, there are no cures for movement 
disorder conditions; however, accurate and early diagnosis can help lessen the effects 
through effective management of the disease. Unfortunately, for most movement 
disorders, diagnosis proves to be difficult and unreliable and requires experts in the field 
to achieve higher accuracy. This is largely due to the fact that the diagnosis of movement 
disorders remains clinical. Clinical diagnosis is based on observation of clinical features 
from examination and history taking and response to medication. Clinical diagnosis is not 
straightforward, usually complex and may be variable. This is the main reason why 
misdiagnosis rate in movement disorders are high. In Parkinson’s disease, it is estimated 
that the misdiagnosis rate remains as high as 25% since 1970’s (Ali H Rajput & Rajput, 
2014). About one in three patients with other tremor conditions were misdiagnosed as 
having ET, with the most frequent incorrect diagnoses being Parkinson’s disease and 
dystonia (Jain et al., 2006). In additon, due to their sometimes-unusual presentations, 
patients with movement disorders may be diagnosed as having disorders caused by 
phycological problems (psychogenic movement disorders, PMD). The misdiagnosed rate 
of PMD is also high at 25-52% (Pal, 2011). 
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In effort to overcome difficulties caused by clinical diagnosis, objective assessments have 
been suggested. Many previous potential objective assessment methods in movement 
disorders are based on motor symptoms. The studies include using electronic sensors to 
collect movement data. For example, using patient’s performance in drawing an 
Archimedes spiral, handwriting, rapid alternate movement or doing an everyday task such 
as walking. From these studies, many important movement features have been extracted 
and proven as significant features in differentiating the groups healthy old people and 
movement disorders. However, statistical analysis applied in these studies is usually 
focused on understanding the data (descriptive statistics) and making statements about 
the analysis of in-hand data (inference). Statistical analysis is often poor in the prediction of 
unseen data points. In order to support clinical diagnosis, the prediction part is obviously 
crucial. The ability to put unseen data into the correct classes, without any prior 
assumptions about the data can, however, be achieved by classification tasks using 
machine learning methods. 
Considering previous efforts towards objective diagnosis, this study was 
conducted by employing EA on kinematic data of standard motor tasks. First, movement 
data collection was done by clinicians and consultant Neurologist in two research centres, 
Leeds Teaching Hospitals NHS Trust, UK and Monash Medical Centre, Melbourne, 
Australia. In the first phase, healthy controls and idiopathic PD patients were recruited. 
A total of 26 controls and 27 PD patients finished three standard motor tasks from MDS-
UPDRS, namely finger tapping (FT), hand pronation-supination (PS) and hand opening-
closing (HO). The movement data were collected in form of recordings of the positions 
of electromagnetic sensors worn by participants. Polhemus, a motion tracker system was 
used for the purpose. In the second phase, 11 HD patients and 6 ET patients were 
recruited. The last phase involved data collection of Dystonia patients. 
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The obtained data was then pre-processed using the Digital Signal Processing Toolbox™ 
in MATLAB®. Simple filtering, a Butterworth filter, was used to filter out noise. 
Exploration of the data were done to understand the data. Every data file was plotted, 
checked for missing values and corruption. For example, the maximum distance between 
two sensors can indicate if the data was corrupted. This can happen if there were strong 
magnetic sources around the motion tracking system or the basic arrangement of the 
experiment protocol was not followed. The details of the recording process is explained 
in Chapter 4. 
The next step is to extract useful features that might be able to differentiate 
movement of participants from different groups. Focus was on features of Bradykinesia. 
This is due to the importance of Bradykinesia feature in PD as explained in Chapter 2. 
Previous quantitative studies of PD were used as basis for features selected. For finger 
tapping and pronation-supination, 19 movement features were extracted. In case of hand-
opening task, 15 features were extracted. The same features in PS and FT cannot be used 
for HO due to the different nature of HO movement. Unlike in FT, where distance of 
thumb and finger are basis of the extracted features, most of the features in HO considered 
the movement of the thumb and fingers separately. Basic statistical tests were conducted 
to find out if there were significant differences between groups of healthy controls and 
the movement disorders data. The extracted features were then used as inputs to evolve 
CGP classifiers. CGP’s advantages were discussed in Chapter 3. A CGP platform (and 
library) was used to evolve the classifiers (Turner & Miller, 2014). These classifiers were 
trained and validated to differentiate groups of healthy elderly people (controls) and 




The disorders considered are Parkinson’s disease, Huntington Disease patients and 
Essential Tremor. Altogether, there are six cases considered in this study: 
 
• Controls vs PD 
• Controls vs HD 
• Controls vs ET 
• PD vs HD 
• PD vs ET 
• Controls vs Dystonia 
• Organic Dystonia vs Functional Dystonia (OD vs FD). 
 
Based on the accuracies of evolved CGP classifiers, the best classifiers were selected to 
investigate features that contributed most to the discrimination. Only classifiers from the 
cases that achieved avaerged accuracies above 80% were considered. 
Other machine learning algorithms were also used for comparison and validation. 
Two popular machine learning algorithms, Support Vector Machines (SVMs) and 
Artificial Neural networks (ANNs) were chosen. Accuracy is used to measure the 
performance of classifiers evolved and two forms of cross-validation (cv) were applied. 
The first approach was to use subject-wise cv where records (repetitions of recordings) 
from the same participant are not used in both the training and the test sets of the same 
fold. This is to avoid dependency between instances in training and test set that may cause 
bias. Stratified repeated k-fold cross-validation was used to assure statistical significance. 
However, it is quite common practice to disregard the precaution and instances from the 
same participant picked randomly to be included in both the training and test sets (record- 
wise cv). Therefore, it was decided to use both approaches to provide a meanful 
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comparison. Therefore, record-wise cv was used to compare performance of the three 
algorithms (CGP, SVM and ANN) with previous studies. 
7.2 Study findings and future works 
This study used one set of experiments with applications to different groups of movement 
disorders. To the best of knowledge, this is the first time a machine learning study that 
the three components (motor tasks) from the UPDRS have been measured together on the 
same patient. This is also the first time that comparisons were made between the 
performances of machine learning classifiers evolved using the kinematic data of all the 
three components.  
7.2.1 Study findings 
To conclude the study, useful findings on the application of EA and other machine 
learning algorithms on the kinematic data of the motor tasks are presented. Following, are 
conclusions and observations that can be made based on the results of the classification 
results and scrutinisation of the chromosomes from the best classifiers evolved. 
 
i) CGP Classifiers using PS kinematic data performed better than FT 
classifiers in PD study 
In the PD study, CGP classifiers had been evolved using kinematic data of three types of 
motor tasks; finger tapping (FT), hand pronation-supination (PS) and hand opening- 
closing. These classifiers were trained and validated to differentiate groups of healthy 
elderly people (controls) and movement disorders patients. The disorders considered were 
Parkinson’s disease, Huntington Disease and Essential Tremor. In all five cases 
considered for the classification task involving PD and other movement disorders (listed 
in section 7.1), PS classifiers showed the highest accuracies compared to classifiers 
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evolved using the other two tasks. This indicates that Rapid Alternating Movements 
(RAM) such as hand pronation-supination might be a better motor task to differentiate 
PD from healthy controls and other movement disorders, compared to finger tapping. 
 
ii) HO classifiers differentiate PD from HD better than FT classifiers 
FT classifier accuracies are comparable to PS classifiers in most cases except for the case 
of PD vs HD, where FT classifiers achieved accuracy of 70% at best. HO classifiers 
showed less convincing performance with the majority of the classifiers’ accuracies 
ranging from 65 % to 78%, in all cases except for the case of PD vs HD, where averaged 
best run achieved an accuracy of 84%. This indicates that HO is a better task to use in 
differentiating PD from HD. 
 
iii) Bradykinesia exists in HD and ET 
There is research suggesting that bradykinesia is not a core feature of movement 
disturbance in HD (Duval et al., n.d.; Fenney et al., 2008). It is interesting to note that in 
this research, the only feature of Bradykinesia considered was slowness, when in fact 
Bradykinesia comprises other features, as explained in Chapter 2. The same pattern 
occurred in the case of Essential Tremor. Some researchers suggested Bradykinesia exists 
in ET (Duval et al., 2006; Goubault et al., 2017), but other research opposes this idea 
(Özekmekçi, 2005). Looking at the results of this study, classification in the majority of 
classifiers, be it using CGP, SVM or ANN (for all three motor tasks), achieved at least 
80% accuracy in identifying HD from healthy controls. Several high-performance 
classifiers even achieved 100% accuracies in classifying HD. Since the movement 
features used to induce the classifiers are Bradykinesia features, it is concluded that 
Bradykinesia does exists in HD. Excellent results were also achieved in classification of 
ET and healthy controls. However, because of the small number of ET patients it can’t be 
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confirmed with confidence, but it is a strong indication that bradykinesia exists in ET, but 
will need further clarification with higher numbers of participants in the future. 
 
iv) Strong discriminative movement features are present in classifications with 
high accuracies 
For classifiers that showed good performance, with averaged accuracies above 80%, the 
best discriminative movement features were investigated. For every case considered, the 
five best classifiers were investigated, by rank-ordering the movement features most 
influential in finding the solution, and identifying these as discriminating features. In case 
of controls vs PD, two of the discriminating features are established characteristics in 
identifying PD (from previous objective assessment studies). This gives more confidence 
in the findings. Discriminative features for every case considered were summarised in 
Chapter 5. The ability of CGP to inform how the solution was achieved is very important 
and is especially useful in future clinical studies. 
 
v) Classification using CGP is in all cases comparable with, and in certain cases 
better than, ANN and SVM 
Accuracies of CGP classifiers in all cases were compared to classifiers induced by SVM 
and ANN. SVM and ANN results are used as a baseline to validate the results obtained 
using CGP. In all cases, accuracies of CGP classifiers are comparable to those obtained 
using SVM and ANN. In the case of controls vs PD, and controls vs ET, CGP classifiers 
even achieved higher accuracies than SVM and ANN. 
 
vi) Record-wise cross-validation yielded better accuracies than subject-wise 
cross-validation in most of the cases 
In record-wise validation, all the records were used as different samples and randomly 
divided into the training and test set datasets. Whilst in subject-wise validation, the 
records for the same subject will not be in the training and test set in the same iteration. 
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We were taking advantage of having real medical data  to test the effect of using different 
style of cross-validation. The results showed that record-wise cross-validation yielded 
better accuracies than subject-wise cross-validation in most cases. This might be a sign 
of bias and overestimating as claimed in (Saeb et al., 2016); however further clarification 
is needed. All SVM and ANN classifiers induced in this study were achieved using record-
wise cross-validation; a practice that is common. For example, leave one out cross-
validation is a type of record-wise cross-validation. 
 
 
vii) Organic and Functional Dystonia cannot be clearly differentiated using the 
same FT movement features in PD study 
The movement features of FT have been used to differentiate between organic and 
functional Dystonia. The classification results were not very encouraging with averaged 
accuracies below 80%. Early statistically significance tests done on the at the beginning 
of the experiments shown promising results. However, as we include more participants, 
the performance decreased. There are few factors that might be the reasons of the lack of 
good performance by the classifiers. The first is, the classification between OD and FD - 
itself a very difficult clinical case. No study known has been successful in objectively 
differentiating between these two types of Dystonia. The second reason might be the 
motor task selected to evolve the classifiers is not suitable to measure the differences 
between the two groups. Finally, it may not be possible to differentiate between OD and 
FD by movement features alone as noe difference is actually expressed. Further work 





7.2.2 Future work 
This study has two main limitations: 
• The electromagnetic sensors were put at the same places during all motor tasks 
although the nature of movement for each task might be different. 
• The small number of participants for the HD and ET studies. 
 
In future work, new experiments should be considered for movement data collection. The 
electromagnetic sensors should be placed at suitable locations according to the task. For 
example, in case of hand pronation-supination, a sensor placed at wrist and another at 
thumb or finger might lead to better results. This way, the angels of movement can be 
measured. In case of Dystonia study, other motor tasks should be considered as well apart 
from finger tapping. 
Although classifications of HD cases yielded very good accuracies, a higher number of 
participants will give more confidence in the accuracies and discriminating features 
achieved. As for ET cases, the classification in this study can be regarded as pilot study 
or preliminary experimentation to a future study with more participants. Another 
suggestion is to use a smaller set of features as CGP classifiers inputs. CGP is an 
algorithm than can predict solutions without any prior assumption and able to process any 
type and distribution of data. Also, this structure should be taken advantage of by using 
raw data points as inputs instead of using a set of features. This way, new movement 





7.3 Final conclusions 
Having summarised, this study in Section 7.1 and highlighted the useful findings in 
Section 7.2, we can now revisit the hypothesis defined in section 1.6: 
 
“Evolutionary Algorithms offer a means of differentiating and characterising a range of 
movement disorders using digitised kinematic data from common conventional clinical 
tasks.” 
 
In order to test the hypothesis, three study objectives were set: 
• Apply EA predictive modelling to classify Parkinson’s disease patients from 
healthy controls, essential tremor and Huntington’s disease patients using 
available datasets. 
• Observe characteristics of different movement disorders performing the same 
motor tasks by analysing the EA classifiers evolved. 
• Use EAs to discriminate patients of functional (psychogenic) dystonia from 
healthy controls, and its organic counterpart, primary dystonia. 
 
In Chapter 5, we concluded that CGP successfully differentiated PD from healthy 
controls, PD and ET. Although in order to generalise the results and inform clinical 
assessment, further clarifications are needed by increasing the number of participants. We 
also highlighted that one of the CGP advantages is the ability to investigate the solution. 
In this case, the study on the chromosomes of the best classifiers exposed the most 
discriminating features of that differentiated each group. 
In Chapter 6, it was presented that the performance of Dystonia classification is 
not so encouraging. Nonetheless, it shows the positive trends where the almost all the 
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classifiers evolved achieved accuracies above 65%. With further work as suggested in 
Section 7.2, we believed better results can be obtained. 
In light of experimental results presented in Chapter 5 and 6, a case can be made 
that Evolutionary Algorithms in form of Cartesian Genetic Programming offer a means 
of differentiating and characterising a range of movement disorders specifically 
Parkinson’s disease, Huntington’s disease and Essential Tremor using digitised 
kinematic data from common conventional clinical tasks of MDS-UPDRS, namely finger 
tapping, hand pronation-supination and hand opening-closing. It is hoped that this study 
can be used as the foundation to further efforts of using EAs in supporting clinical 
diagnosis of movement disorders. This study can be extended in many ways such as 
application to other types of movement disorders, or using kinematic data of other motor 
tasks, or using components from other assessment scales. 
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